id	sid	tid	token	lemma	pos
eurjchem-1084	1	1	untitled	untitle	VERB
eurjchem-1084	1	2	european	european	PROPN
eurjchem-1084	1	3	journal	journal	PROPN
eurjchem-1084	1	4	of	of	ADP
eurjchem-1084	1	5	chemistry	chemistry	NOUN
eurjchem-1084	1	6	5	5	NUM
eurjchem-1084	1	7	(	(	PUNCT
eurjchem-1084	1	8	3	3	NUM
eurjchem-1084	1	9	)	)	PUNCT
eurjchem-1084	1	10	(	(	PUNCT
eurjchem-1084	1	11	2014	2014	NUM
eurjchem-1084	1	12	)	)	PUNCT
eurjchem-1084	1	13	529‐531	529‐531	NUM
eurjchem-1084	1	14	european	european	ADJ
eurjchem-1084	1	15	journal	journal	PROPN
eurjchem-1084	1	16	of	of	ADP
eurjchem-1084	1	17	chemistry	chemistry	NOUN
eurjchem-1084	1	18	issn	issn	PROPN
eurjchem-1084	1	19	2153‐2249	2153‐2249	PROPN
eurjchem-1084	1	20	(	(	PUNCT
eurjchem-1084	1	21	print	print	NOUN
eurjchem-1084	1	22	)	)	PUNCT
eurjchem-1084	1	23	/	/	SYM
eurjchem-1084	1	24	issn	issn	PROPN
eurjchem-1084	1	25	2153‐2257	2153‐2257	NUM
eurjchem-1084	1	26	(	(	PUNCT
eurjchem-1084	1	27	online	online	ADJ
eurjchem-1084	1	28	)	)	PUNCT
eurjchem-1084	1	29			NOUN
eurjchem-1084	1	30	2014	2014	NUM
eurjchem-1084	2	1	eurjchem	eurjchem	PROPN
eurjchem-1084	2	2	publishing	publish	VERB
eurjchem-1084	2	3	‐	‐	NOUN
eurjchem-1084	2	4	printed	print	VERB
eurjchem-1084	2	5	in	in	ADP
eurjchem-1084	2	6	the	the	DET
eurjchem-1084	2	7	usa	usa	PROPN
eurjchem-1084	2	8	http://dx.doi.org/10.5155/eurjchem.5.3.529‐531.1084	http://dx.doi.org/10.5155/eurjchem.5.3.529‐531.1084	PROPN
eurjchem-1084	2	9	european	european	PROPN
eurjchem-1084	2	10	journal	journal	PROPN
eurjchem-1084	2	11	of	of	ADP
eurjchem-1084	2	12	chemistry	chemistry	PROPN
eurjchem-1084	2	13	journal	journal	PROPN
eurjchem-1084	2	14	homepage	homepage	NOUN
eurjchem-1084	2	15	:	:	PUNCT
eurjchem-1084	2	16	www.eurjchem.com	www.eurjchem.com	X
eurjchem-1084	2	17	investigate	investigate	VERB
eurjchem-1084	2	18	the	the	DET
eurjchem-1084	2	19	level	level	NOUN
eurjchem-1084	2	20	of	of	ADP
eurjchem-1084	2	21	il‐8	il‐8	NOUN
eurjchem-1084	2	22	in	in	ADP
eurjchem-1084	2	23	patients	patient	NOUN
eurjchem-1084	2	24	with	with	ADP
eurjchem-1084	2	25	diabetes	diabetes	NOUN
eurjchem-1084	2	26	mellitus	mellitus	NOUN
eurjchem-1084	2	27	and	and	CCONJ
eurjchem-1084	2	28	its	its	PRON
eurjchem-1084	2	29	relation	relation	NOUN
eurjchem-1084	2	30	with	with	ADP
eurjchem-1084	2	31	lipid	lipid	NOUN
eurjchem-1084	2	32	profile	profile	NOUN
eurjchem-1084	2	33	and	and	CCONJ
eurjchem-1084	2	34	the	the	DET
eurjchem-1084	2	35	incidence	incidence	NOUN
eurjchem-1084	2	36	of	of	ADP
eurjchem-1084	2	37	atherosclerosis	atherosclerosis	NOUN
eurjchem-1084	2	38	ammal	ammal	ADJ
eurjchem-1084	2	39	esmaeel	esmaeel	NOUN
eurjchem-1084	2	40	ibrahim	ibrahim	PROPN
eurjchem-1084	2	41	department	department	PROPN
eurjchem-1084	2	42	of	of	ADP
eurjchem-1084	2	43	chemistry	chemistry	NOUN
eurjchem-1084	2	44	,	,	PUNCT
eurjchem-1084	2	45	college	college	NOUN
eurjchem-1084	2	46	of	of	ADP
eurjchem-1084	2	47	science	science	NOUN
eurjchem-1084	2	48	,	,	PUNCT
eurjchem-1084	2	49	al‐nahrain	al‐nahrain	PROPN
eurjchem-1084	2	50	university	university	PROPN
eurjchem-1084	2	51	,	,	PUNCT
eurjchem-1084	2	52	baghdad	baghdad	PROPN
eurjchem-1084	2	53	,	,	PUNCT
eurjchem-1084	2	54	10072	10072	NUM
eurjchem-1084	2	55	,	,	PUNCT
eurjchem-1084	2	56	iraq	iraq	PROPN
eurjchem-1084	2	57	*	*	PUNCT
eurjchem-1084	2	58	corresponding	correspond	VERB
eurjchem-1084	2	59	author	author	NOUN
eurjchem-1084	2	60	at	at	ADP
eurjchem-1084	2	61	:	:	PUNCT
eurjchem-1084	2	62	department	department	NOUN
eurjchem-1084	2	63	of	of	ADP
eurjchem-1084	2	64	chemistry	chemistry	NOUN
eurjchem-1084	2	65	,	,	PUNCT
eurjchem-1084	2	66	college	college	NOUN
eurjchem-1084	2	67	of	of	ADP
eurjchem-1084	2	68	science	science	NOUN
eurjchem-1084	2	69	,	,	PUNCT
eurjchem-1084	2	70	al‐nahrain	al‐nahrain	PROPN
eurjchem-1084	2	71	university	university	PROPN
eurjchem-1084	2	72	,	,	PUNCT
eurjchem-1084	2	73	baghdad	baghdad	PROPN
eurjchem-1084	2	74	,	,	PUNCT
eurjchem-1084	2	75	10072	10072	NUM
eurjchem-1084	2	76	,	,	PUNCT
eurjchem-1084	2	77	iraq	iraq	PROPN
eurjchem-1084	2	78	.	.	PUNCT
eurjchem-1084	3	1	tel	tel	PROPN
eurjchem-1084	3	2	.	.	PUNCT
eurjchem-1084	3	3	:	:	PUNCT
eurjchem-1084	4	1	+964.0790.1566784	+964.0790.1566784	X
eurjchem-1084	4	2	.	.	PUNCT
eurjchem-1084	5	1	fax	fax	NOUN
eurjchem-1084	5	2	:	:	PUNCT
eurjchem-1084	5	3	+964.0790.1566784	+964.0790.1566784	PROPN
eurjchem-1084	5	4	.	.	PUNCT
eurjchem-1084	5	5	e‐mail	e‐mail	PUNCT
eurjchem-1084	6	1	address	address	NOUN
eurjchem-1084	6	2	:	:	PUNCT
eurjchem-1084	6	3	dr.ammalalobaidi@yahoo.com	dr.ammalalobaidi@yahoo.com	PROPN
eurjchem-1084	6	4	(	(	PUNCT
eurjchem-1084	6	5	a.e	a.e	PROPN
eurjchem-1084	6	6	.	.	PROPN
eurjchem-1084	6	7	ibrahim	ibrahim	PROPN
eurjchem-1084	6	8	)	)	PUNCT
eurjchem-1084	6	9	.	.	PUNCT
eurjchem-1084	7	1	article	article	NOUN
eurjchem-1084	7	2	information	information	PROPN
eurjchem-1084	7	3	abstract	abstract	ADJ
eurjchem-1084	7	4	doi	doi	NOUN
eurjchem-1084	7	5	:	:	PUNCT
eurjchem-1084	7	6	10.5155	10.5155	NUM
eurjchem-1084	7	7	/	/	SYM
eurjchem-1084	7	8	eurjchem.5.3.529‐531.1084	eurjchem.5.3.529‐531.1084	VERB
eurjchem-1084	7	9	received	receive	VERB
eurjchem-1084	7	10	:	:	PUNCT
eurjchem-1084	7	11	25	25	NUM
eurjchem-1084	7	12	april	april	PROPN
eurjchem-1084	7	13	2014	2014	NUM
eurjchem-1084	7	14	received	receive	VERB
eurjchem-1084	7	15	in	in	ADP
eurjchem-1084	7	16	revised	revise	VERB
eurjchem-1084	7	17	form	form	NOUN
eurjchem-1084	7	18	:	:	PUNCT
eurjchem-1084	7	19	23	23	NUM
eurjchem-1084	7	20	may	may	AUX
eurjchem-1084	7	21	2014	2014	NUM
eurjchem-1084	7	22	accepted	accept	VERB
eurjchem-1084	7	23	:	:	PUNCT
eurjchem-1084	7	24	06	06	NUM
eurjchem-1084	7	25	june	june	PROPN
eurjchem-1084	7	26	2014	2014	NUM
eurjchem-1084	7	27	online	online	NOUN
eurjchem-1084	7	28	:	:	PUNCT
eurjchem-1084	7	29	30	30	NUM
eurjchem-1084	7	30	september	september	PROPN
eurjchem-1084	7	31	2014	2014	NUM
eurjchem-1084	7	32	keywords	keyword	NOUN
eurjchem-1084	7	33	il‐8	il‐8	PRON
eurjchem-1084	7	34	is	be	AUX
eurjchem-1084	7	35	a	a	DET
eurjchem-1084	7	36	member	member	NOUN
eurjchem-1084	7	37	of	of	ADP
eurjchem-1084	7	38	the	the	DET
eurjchem-1084	7	39	cxc	cxc	NOUN
eurjchem-1084	7	40	class	class	NOUN
eurjchem-1084	7	41	of	of	ADP
eurjchem-1084	7	42	chemokines	chemokine	NOUN
eurjchem-1084	7	43	and	and	CCONJ
eurjchem-1084	7	44	is	be	AUX
eurjchem-1084	7	45	chemotactic	chemotactic	ADJ
eurjchem-1084	7	46	for	for	ADP
eurjchem-1084	7	47	neutrophils	neutrophil	NOUN
eurjchem-1084	7	48	.	.	PUNCT
eurjchem-1084	8	1	the	the	DET
eurjchem-1084	8	2	cellular	cellular	ADJ
eurjchem-1084	8	3	activation	activation	NOUN
eurjchem-1084	8	4	of	of	ADP
eurjchem-1084	8	5	il‐8	il‐8	PROPN
eurjchem-1084	8	6	takes	take	VERB
eurjchem-1084	8	7	place	place	NOUN
eurjchem-1084	8	8	after	after	SCONJ
eurjchem-1084	8	9	il‐8	il‐8	NOUN
eurjchem-1084	8	10	binding	bind	VERB
eurjchem-1084	8	11	to	to	ADP
eurjchem-1084	8	12	its	its	PRON
eurjchem-1084	8	13	receptor	receptor	NOUN
eurjchem-1084	8	14	in	in	ADP
eurjchem-1084	8	15	the	the	DET
eurjchem-1084	8	16	presence	presence	NOUN
eurjchem-1084	8	17	of	of	ADP
eurjchem-1084	8	18	calcium	calcium	NOUN
eurjchem-1084	8	19	and	and	CCONJ
eurjchem-1084	8	20	protein	protein	NOUN
eurjchem-1084	8	21	kinase	kinase	NOUN
eurjchem-1084	8	22	,	,	PUNCT
eurjchem-1084	8	23	leading	lead	VERB
eurjchem-1084	8	24	to	to	ADP
eurjchem-1084	8	25	neutrophil	neutrophil	ADJ
eurjchem-1084	8	26	activation	activation	NOUN
eurjchem-1084	8	27	and	and	CCONJ
eurjchem-1084	8	28	chemo	chemo	VERB
eurjchem-1084	8	29	taxis	taxi	NOUN
eurjchem-1084	8	30	in	in	ADP
eurjchem-1084	8	31	infection	infection	NOUN
eurjchem-1084	8	32	and	and	CCONJ
eurjchem-1084	8	33	inflammation	inflammation	NOUN
eurjchem-1084	8	34	.	.	PUNCT
eurjchem-1084	9	1	therefore	therefore	ADV
eurjchem-1084	9	2	,	,	PUNCT
eurjchem-1084	9	3	il‐8	il‐8	PROPN
eurjchem-1084	9	4	tasks	task	NOUN
eurjchem-1084	9	5	to	to	PART
eurjchem-1084	9	6	mediate	mediate	VERB
eurjchem-1084	9	7	neutrophil	neutrophil	ADJ
eurjchem-1084	9	8	recruitment	recruitment	NOUN
eurjchem-1084	9	9	,	,	PUNCT
eurjchem-1084	9	10	accumulation	accumulation	NOUN
eurjchem-1084	9	11	,	,	PUNCT
eurjchem-1084	9	12	and	and	CCONJ
eurjchem-1084	9	13	activation	activation	NOUN
eurjchem-1084	9	14	.	.	PUNCT
eurjchem-1084	10	1	the	the	DET
eurjchem-1084	10	2	study	study	NOUN
eurjchem-1084	10	3	included	include	VERB
eurjchem-1084	10	4	50	50	NUM
eurjchem-1084	10	5	patients	patient	NOUN
eurjchem-1084	10	6	with	with	ADP
eurjchem-1084	10	7	diabetes	diabetes	NOUN
eurjchem-1084	10	8	mellitus	mellitus	NOUN
eurjchem-1084	10	9	divided	divide	VERB
eurjchem-1084	10	10	into	into	ADP
eurjchem-1084	10	11	a	a	DET
eurjchem-1084	10	12	female	female	ADJ
eurjchem-1084	10	13	group	group	NOUN
eurjchem-1084	10	14	,	,	PUNCT
eurjchem-1084	10	15	which	which	PRON
eurjchem-1084	10	16	contained	contain	VERB
eurjchem-1084	10	17	16	16	NUM
eurjchem-1084	10	18	female	female	ADJ
eurjchem-1084	10	19	patients	patient	NOUN
eurjchem-1084	10	20	with	with	ADP
eurjchem-1084	10	21	an	an	DET
eurjchem-1084	10	22	age	age	NOUN
eurjchem-1084	10	23	range	range	NOUN
eurjchem-1084	10	24	of	of	ADP
eurjchem-1084	10	25	39‐69	39‐69	NUM
eurjchem-1084	10	26	years	year	NOUN
eurjchem-1084	10	27	,	,	PUNCT
eurjchem-1084	10	28	and	and	CCONJ
eurjchem-1084	10	29	a	a	DET
eurjchem-1084	10	30	male	male	ADJ
eurjchem-1084	10	31	group	group	NOUN
eurjchem-1084	10	32	which	which	PRON
eurjchem-1084	10	33	contained	contain	VERB
eurjchem-1084	10	34	34	34	NUM
eurjchem-1084	10	35	male	male	ADJ
eurjchem-1084	10	36	patients	patient	NOUN
eurjchem-1084	10	37	with	with	ADP
eurjchem-1084	10	38	an	an	DET
eurjchem-1084	10	39	age	age	NOUN
eurjchem-1084	10	40	range	range	NOUN
eurjchem-1084	10	41	of	of	ADP
eurjchem-1084	10	42	40‐72	40‐72	NUM
eurjchem-1084	10	43	years	year	NOUN
eurjchem-1084	10	44	.	.	PUNCT
eurjchem-1084	11	1	control	control	NOUN
eurjchem-1084	11	2	groups	group	NOUN
eurjchem-1084	11	3	contained	contain	VERB
eurjchem-1084	11	4	forty	forty	NUM
eurjchem-1084	11	5	healthy	healthy	ADJ
eurjchem-1084	11	6	individuals	individual	NOUN
eurjchem-1084	11	7	divided	divide	VERB
eurjchem-1084	11	8	into	into	ADP
eurjchem-1084	11	9	a	a	DET
eurjchem-1084	11	10	female	female	ADJ
eurjchem-1084	11	11	group	group	NOUN
eurjchem-1084	11	12	,	,	PUNCT
eurjchem-1084	11	13	which	which	PRON
eurjchem-1084	11	14	contained	contain	VERB
eurjchem-1084	11	15	16	16	NUM
eurjchem-1084	11	16	healthy	healthy	ADJ
eurjchem-1084	11	17	females	female	NOUN
eurjchem-1084	11	18	with	with	ADP
eurjchem-1084	11	19	an	an	DET
eurjchem-1084	11	20	age	age	NOUN
eurjchem-1084	11	21	range	range	NOUN
eurjchem-1084	11	22	of	of	ADP
eurjchem-1084	11	23	35‐68	35‐68	NUM
eurjchem-1084	11	24	years	year	NOUN
eurjchem-1084	11	25	,	,	PUNCT
eurjchem-1084	11	26	and	and	CCONJ
eurjchem-1084	11	27	a	a	DET
eurjchem-1084	11	28	male	male	ADJ
eurjchem-1084	11	29	group	group	NOUN
eurjchem-1084	11	30	which	which	PRON
eurjchem-1084	11	31	contained	contain	VERB
eurjchem-1084	11	32	24	24	NUM
eurjchem-1084	11	33	males	male	NOUN
eurjchem-1084	11	34	with	with	ADP
eurjchem-1084	11	35	an	an	DET
eurjchem-1084	11	36	age	age	NOUN
eurjchem-1084	11	37	range	range	NOUN
eurjchem-1084	11	38	of	of	ADP
eurjchem-1084	11	39	39‐	39‐	NUM
eurjchem-1084	11	40	69	69	NUM
eurjchem-1084	11	41	years	year	NOUN
eurjchem-1084	11	42	.	.	PUNCT
eurjchem-1084	12	1	elisa	elisa	PROPN
eurjchem-1084	12	2	kits	kit	NOUN
eurjchem-1084	12	3	were	be	AUX
eurjchem-1084	12	4	used	use	VERB
eurjchem-1084	12	5	to	to	PART
eurjchem-1084	12	6	measure	measure	VERB
eurjchem-1084	12	7	insulin	insulin	NOUN
eurjchem-1084	12	8	and	and	CCONJ
eurjchem-1084	12	9	il‐8	il‐8	PROPN
eurjchem-1084	12	10	.	.	PUNCT
eurjchem-1084	13	1	the	the	DET
eurjchem-1084	13	2	levels	level	NOUN
eurjchem-1084	13	3	of	of	ADP
eurjchem-1084	13	4	insulin	insulin	NOUN
eurjchem-1084	13	5	and	and	CCONJ
eurjchem-1084	13	6	il‐8	il‐8	NOUN
eurjchem-1084	13	7	were	be	AUX
eurjchem-1084	13	8	considerably	considerably	ADV
eurjchem-1084	13	9	elevated	elevate	VERB
eurjchem-1084	13	10	throughout	throughout	ADV
eurjchem-1084	13	11	(	(	PUNCT
eurjchem-1084	13	12	p	p	X
eurjchem-1084	13	13	<	<	X
eurjchem-1084	13	14	0.001	0.001	NUM
eurjchem-1084	13	15	)	)	PUNCT
eurjchem-1084	13	16	,	,	PUNCT
eurjchem-1084	13	17	total	total	ADJ
eurjchem-1084	13	18	cholesterol	cholesterol	NOUN
eurjchem-1084	13	19	,	,	PUNCT
eurjchem-1084	13	20	low	low	ADJ
eurjchem-1084	13	21	density	density	NOUN
eurjchem-1084	13	22	lipoprotein	lipoprotein	ADJ
eurjchem-1084	13	23	(	(	PUNCT
eurjchem-1084	13	24	ldl	ldl	NOUN
eurjchem-1084	13	25	)	)	PUNCT
eurjchem-1084	13	26	,	,	PUNCT
eurjchem-1084	13	27	were	be	AUX
eurjchem-1084	13	28	significantly	significantly	ADV
eurjchem-1084	13	29	elevated	elevate	VERB
eurjchem-1084	13	30	(	(	PUNCT
eurjchem-1084	13	31	p	p	X
eurjchem-1084	13	32	<	<	X
eurjchem-1084	13	33	0.001	0.001	NUM
eurjchem-1084	13	34	)	)	PUNCT
eurjchem-1084	13	35	in	in	ADP
eurjchem-1084	13	36	all	all	DET
eurjchem-1084	13	37	patients	patient	NOUN
eurjchem-1084	13	38	as	as	ADV
eurjchem-1084	13	39	well	well	ADV
eurjchem-1084	13	40	.	.	PUNCT
eurjchem-1084	14	1	there	there	PRON
eurjchem-1084	14	2	was	be	VERB
eurjchem-1084	14	3	positive	positive	ADJ
eurjchem-1084	14	4	correlation	correlation	NOUN
eurjchem-1084	14	5	between	between	ADP
eurjchem-1084	14	6	interleukin‐8	interleukin‐8	NOUN
eurjchem-1084	14	7	with	with	ADP
eurjchem-1084	14	8	ldl	ldl	NOUN
eurjchem-1084	14	9	,	,	PUNCT
eurjchem-1084	14	10	while	while	SCONJ
eurjchem-1084	14	11	there	there	PRON
eurjchem-1084	14	12	was	be	VERB
eurjchem-1084	14	13	negative	negative	ADJ
eurjchem-1084	14	14	correlation	correlation	NOUN
eurjchem-1084	14	15	with	with	ADP
eurjchem-1084	14	16	total	total	ADJ
eurjchem-1084	14	17	cholesterol	cholesterol	NOUN
eurjchem-1084	14	18	and	and	CCONJ
eurjchem-1084	14	19	high	high	ADJ
eurjchem-1084	14	20	density	density	NOUN
eurjchem-1084	14	21	lipoprotein	lipoprotein	ADJ
eurjchem-1084	14	22	(	(	PUNCT
eurjchem-1084	14	23	hdl	hdl	NOUN
eurjchem-1084	14	24	)	)	PUNCT
eurjchem-1084	14	25	.	.	PUNCT
eurjchem-1084	15	1	interleukin‐8	interleukin‐8	VERB
eurjchem-1084	15	2	levels	level	NOUN
eurjchem-1084	15	3	increase	increase	VERB
eurjchem-1084	15	4	with	with	ADP
eurjchem-1084	15	5	obesity	obesity	NOUN
eurjchem-1084	15	6	in	in	ADP
eurjchem-1084	15	7	patients	patient	NOUN
eurjchem-1084	15	8	and	and	CCONJ
eurjchem-1084	15	9	control	control	NOUN
eurjchem-1084	15	10	groups	group	NOUN
eurjchem-1084	15	11	,	,	PUNCT
eurjchem-1084	15	12	interleukin‐8	interleukin‐8	PUNCT
eurjchem-1084	15	13	positively	positively	ADV
eurjchem-1084	15	14	correlated	correlate	VERB
eurjchem-1084	15	15	with	with	ADP
eurjchem-1084	15	16	ldl‐cholesterol	ldl‐cholesterol	NOUN
eurjchem-1084	15	17	and	and	CCONJ
eurjchem-1084	15	18	negatively	negatively	ADV
eurjchem-1084	15	19	correlated	correlate	VERB
eurjchem-1084	15	20	with	with	ADP
eurjchem-1084	15	21	hdl‐c	hdl‐c	NOUN
eurjchem-1084	15	22	thus	thus	ADV
eurjchem-1084	15	23	make	make	VERB
eurjchem-1084	15	24	us	we	PRON
eurjchem-1084	15	25	consider	consider	VERB
eurjchem-1084	15	26	it	it	PRON
eurjchem-1084	15	27	as	as	ADP
eurjchem-1084	15	28	atherogenic	atherogenic	ADJ
eurjchem-1084	15	29	factor	factor	NOUN
eurjchem-1084	15	30	,	,	PUNCT
eurjchem-1084	15	31	the	the	DET
eurjchem-1084	15	32	increase	increase	NOUN
eurjchem-1084	15	33	in	in	ADP
eurjchem-1084	15	34	the	the	DET
eurjchem-1084	15	35	level	level	NOUN
eurjchem-1084	15	36	of	of	ADP
eurjchem-1084	15	37	il‐8	il‐8	NOUN
eurjchem-1084	15	38	in	in	ADP
eurjchem-1084	15	39	patients	patient	NOUN
eurjchem-1084	15	40	who	who	PRON
eurjchem-1084	15	41	have	have	VERB
eurjchem-1084	15	42	diabetes	diabetes	NOUN
eurjchem-1084	15	43	mellitus	mellitus	NOUN
eurjchem-1084	15	44	may	may	AUX
eurjchem-1084	15	45	indicate	indicate	VERB
eurjchem-1084	15	46	increasing	increase	VERB
eurjchem-1084	15	47	the	the	DET
eurjchem-1084	15	48	incidence	incidence	NOUN
eurjchem-1084	15	49	of	of	ADP
eurjchem-1084	15	50	atherosclerosis	atherosclerosis	NOUN
eurjchem-1084	15	51	.	.	PUNCT
eurjchem-1084	16	1	cholesterol	cholesterol	NOUN
eurjchem-1084	16	2	triglycerides	triglyceride	NOUN
eurjchem-1084	16	3	interleukin‐8	interleukin‐8	VERB
eurjchem-1084	16	4	atherosclerosis	atherosclerosis	NOUN
eurjchem-1084	16	5	body	body	NOUN
eurjchem-1084	16	6	mass	mass	NOUN
eurjchem-1084	16	7	index	index	NOUN
eurjchem-1084	16	8	diabetes	diabetes	NOUN
eurjchem-1084	16	9	mellitus	mellitus	NOUN
eurjchem-1084	16	10	1	1	X
eurjchem-1084	16	11	.	.	PUNCT
eurjchem-1084	17	1	introduction	introduction	NOUN
eurjchem-1084	17	2	interleukin‐8	interleukin‐8	ADP
eurjchem-1084	17	3	(	(	PUNCT
eurjchem-1084	17	4	il‐8	il‐8	NOUN
eurjchem-1084	17	5	)	)	PUNCT
eurjchem-1084	17	6	is	be	AUX
eurjchem-1084	17	7	a	a	DET
eurjchem-1084	17	8	chemokine	chemokine	NOUN
eurjchem-1084	17	9	released	release	VERB
eurjchem-1084	17	10	from	from	ADP
eurjchem-1084	17	11	endo‐	endo‐	NOUN
eurjchem-1084	17	12	thelial	thelial	ADJ
eurjchem-1084	17	13	cells	cell	NOUN
eurjchem-1084	17	14	in	in	ADP
eurjchem-1084	17	15	response	response	NOUN
eurjchem-1084	17	16	to	to	ADP
eurjchem-1084	17	17	inflammatory	inflammatory	ADJ
eurjchem-1084	17	18	stimuli	stimulus	NOUN
eurjchem-1084	17	19	[	[	X
eurjchem-1084	17	20	1	1	NUM
eurjchem-1084	17	21	]	]	PUNCT
eurjchem-1084	17	22	.	.	PUNCT
eurjchem-1084	18	1	inter‐	inter‐	NOUN
eurjchem-1084	18	2	leukin‐8	leukin‐8	PROPN
eurjchem-1084	18	3	shows	show	VERB
eurjchem-1084	18	4	a	a	DET
eurjchem-1084	18	5	high	high	ADJ
eurjchem-1084	18	6	affinity	affinity	NOUN
eurjchem-1084	18	7	for	for	ADP
eurjchem-1084	18	8	receptors	receptor	NOUN
eurjchem-1084	18	9	on	on	ADP
eurjchem-1084	18	10	the	the	DET
eurjchem-1084	18	11	plasma	plasma	NOUN
eurjchem-1084	18	12	membranes	membrane	NOUN
eurjchem-1084	18	13	of	of	ADP
eurjchem-1084	18	14	neutrophils	neutrophil	NOUN
eurjchem-1084	18	15	.	.	PUNCT
eurjchem-1084	19	1	cellular	cellular	ADJ
eurjchem-1084	19	2	activation	activation	NOUN
eurjchem-1084	19	3	takes	take	VERB
eurjchem-1084	19	4	place	place	NOUN
eurjchem-1084	19	5	after	after	SCONJ
eurjchem-1084	19	6	il‐8	il‐8	NOUN
eurjchem-1084	19	7	binding	bind	VERB
eurjchem-1084	19	8	in	in	ADP
eurjchem-1084	19	9	the	the	DET
eurjchem-1084	19	10	presence	presence	NOUN
eurjchem-1084	19	11	of	of	ADP
eurjchem-1084	19	12	calcium	calcium	NOUN
eurjchem-1084	19	13	and	and	CCONJ
eurjchem-1084	19	14	protein	protein	NOUN
eurjchem-1084	19	15	kinase	kinase	NOUN
eurjchem-1084	19	16	,	,	PUNCT
eurjchem-1084	19	17	follow‐on	follow‐on	X
eurjchem-1084	19	18	neutrophil	neutrophil	ADJ
eurjchem-1084	19	19	activation	activation	NOUN
eurjchem-1084	19	20	and	and	CCONJ
eurjchem-1084	19	21	chemo	chemo	VERB
eurjchem-1084	19	22	taxis	taxi	NOUN
eurjchem-1084	19	23	in	in	ADP
eurjchem-1084	19	24	infection	infection	NOUN
eurjchem-1084	19	25	and	and	CCONJ
eurjchem-1084	19	26	inflammation	inflammation	NOUN
eurjchem-1084	19	27	.	.	PUNCT
eurjchem-1084	20	1	therefore	therefore	ADV
eurjchem-1084	20	2	il‐8	il‐8	PROPN
eurjchem-1084	20	3	mediates	mediate	NOUN
eurjchem-1084	20	4	neutrophil	neutrophil	ADJ
eurjchem-1084	20	5	recruit‐	recruit‐	NOUN
eurjchem-1084	20	6	ment	ment	NOUN
eurjchem-1084	20	7	,	,	PUNCT
eurjchem-1084	20	8	accumulation	accumulation	NOUN
eurjchem-1084	20	9	,	,	PUNCT
eurjchem-1084	20	10	and	and	CCONJ
eurjchem-1084	20	11	activation	activation	NOUN
eurjchem-1084	20	12	[	[	X
eurjchem-1084	20	13	2	2	NUM
eurjchem-1084	20	14	]	]	PUNCT
eurjchem-1084	20	15	.	.	PUNCT
eurjchem-1084	21	1	insulin	insulin	NOUN
eurjchem-1084	21	2	is	be	AUX
eurjchem-1084	21	3	a	a	DET
eurjchem-1084	21	4	peptide	peptide	ADJ
eurjchem-1084	21	5	hormone	hormone	NOUN
eurjchem-1084	21	6	,	,	PUNCT
eurjchem-1084	21	7	produced	produce	VERB
eurjchem-1084	21	8	in	in	ADP
eurjchem-1084	21	9	pancreas	pancrea	NOUN
eurjchem-1084	21	10	by	by	ADP
eurjchem-1084	21	11	beta	beta	ADJ
eurjchem-1084	21	12	cells	cell	NOUN
eurjchem-1084	21	13	of	of	ADP
eurjchem-1084	21	14	langerhans	langerhans	PROPN
eurjchem-1084	21	15	.	.	PUNCT
eurjchem-1084	22	1	the	the	DET
eurjchem-1084	22	2	human	human	ADJ
eurjchem-1084	22	3	insulin	insulin	NOUN
eurjchem-1084	22	4	protein	protein	NOUN
eurjchem-1084	22	5	is	be	AUX
eurjchem-1084	22	6	composed	compose	VERB
eurjchem-1084	22	7	of	of	ADP
eurjchem-1084	22	8	51	51	NUM
eurjchem-1084	22	9	amino	amino	NOUN
eurjchem-1084	22	10	acids	acid	NOUN
eurjchem-1084	22	11	;	;	PUNCT
eurjchem-1084	22	12	with	with	ADP
eurjchem-1084	22	13	a	a	DET
eurjchem-1084	22	14	molecular	molecular	ADJ
eurjchem-1084	22	15	weight	weight	NOUN
eurjchem-1084	22	16	of	of	ADP
eurjchem-1084	22	17	5808	5808	NUM
eurjchem-1084	22	18	da	da	X
eurjchem-1084	22	19	.	.	PUNCT
eurjchem-1084	23	1	insulin	insulin	NOUN
eurjchem-1084	23	2	consists	consist	VERB
eurjchem-1084	23	3	from	from	ADP
eurjchem-1084	23	4	a	a	DET
eurjchem-1084	23	5	dimer	dimer	NOUN
eurjchem-1084	23	6	of	of	ADP
eurjchem-1084	23	7	an	an	PRON
eurjchem-1084	23	8	a‐chain	a‐chain	PUNCT
eurjchem-1084	23	9	and	and	CCONJ
eurjchem-1084	23	10	a	a	PRON
eurjchem-1084	23	11	b‐chain	b‐chain	PUNCT
eurjchem-1084	23	12	linked	link	VERB
eurjchem-1084	23	13	together	together	ADV
eurjchem-1084	23	14	by	by	ADP
eurjchem-1084	23	15	disulfide	disulfide	NOUN
eurjchem-1084	23	16	bonds	bond	NOUN
eurjchem-1084	23	17	.	.	PUNCT
eurjchem-1084	24	1	insulin	insulin	NOUN
eurjchem-1084	24	2	's	's	PART
eurjchem-1084	24	3	structure	structure	NOUN
eurjchem-1084	24	4	varies	vary	VERB
eurjchem-1084	24	5	slightly	slightly	ADV
eurjchem-1084	24	6	among	among	ADP
eurjchem-1084	24	7	species	specie	NOUN
eurjchem-1084	24	8	of	of	ADP
eurjchem-1084	24	9	animals	animal	NOUN
eurjchem-1084	24	10	.	.	PUNCT
eurjchem-1084	25	1	insulin	insulin	NOUN
eurjchem-1084	25	2	from	from	ADP
eurjchem-1084	25	3	animal	animal	NOUN
eurjchem-1084	25	4	sources	source	NOUN
eurjchem-1084	25	5	differs	differ	VERB
eurjchem-1084	25	6	somewhat	somewhat	ADV
eurjchem-1084	25	7	in	in	ADP
eurjchem-1084	25	8	"	"	PUNCT
eurjchem-1084	25	9	strength	strength	NOUN
eurjchem-1084	25	10	"	"	PUNCT
eurjchem-1084	25	11	from	from	ADP
eurjchem-1084	25	12	that	that	PRON
eurjchem-1084	25	13	in	in	ADP
eurjchem-1084	25	14	humans	human	NOUN
eurjchem-1084	25	15	because	because	SCONJ
eurjchem-1084	25	16	of	of	ADP
eurjchem-1084	25	17	those	those	DET
eurjchem-1084	25	18	variations	variation	NOUN
eurjchem-1084	25	19	.	.	PUNCT
eurjchem-1084	26	1	porcine	porcine	NOUN
eurjchem-1084	26	2	insulin	insulin	NOUN
eurjchem-1084	26	3	is	be	AUX
eurjchem-1084	26	4	especially	especially	ADV
eurjchem-1084	26	5	close	close	ADJ
eurjchem-1084	26	6	to	to	ADP
eurjchem-1084	26	7	the	the	DET
eurjchem-1084	26	8	human	human	ADJ
eurjchem-1084	26	9	version	version	NOUN
eurjchem-1084	26	10	[	[	X
eurjchem-1084	26	11	3	3	NUM
eurjchem-1084	26	12	]	]	PUNCT
eurjchem-1084	26	13	.	.	PUNCT
eurjchem-1084	27	1	hyper‐	hyper‐	AUX
eurjchem-1084	27	2	glycaemia	glycaemia	PROPN
eurjchem-1084	27	3	accrue	accrue	ADJ
eurjchem-1084	27	4	as	as	ADP
eurjchem-1084	27	5	results	result	NOUN
eurjchem-1084	27	6	when	when	SCONJ
eurjchem-1084	27	7	insulin	insulin	NOUN
eurjchem-1084	27	8	not	not	PART
eurjchem-1084	27	9	work	work	NOUN
eurjchem-1084	27	10	properly	properly	ADV
eurjchem-1084	27	11	,	,	PUNCT
eurjchem-1084	27	12	this	this	DET
eurjchem-1084	27	13	condition	condition	NOUN
eurjchem-1084	27	14	could	could	AUX
eurjchem-1084	27	15	be	be	AUX
eurjchem-1084	27	16	toxic	toxic	ADJ
eurjchem-1084	27	17	to	to	ADP
eurjchem-1084	27	18	the	the	DET
eurjchem-1084	27	19	body	body	NOUN
eurjchem-1084	27	20	.	.	PUNCT
eurjchem-1084	28	1	when	when	SCONJ
eurjchem-1084	28	2	blood	blood	NOUN
eurjchem-1084	28	3	glucose	glucose	NOUN
eurjchem-1084	28	4	levels	level	NOUN
eurjchem-1084	28	5	drop	drop	VERB
eurjchem-1084	28	6	below	below	ADP
eurjchem-1084	28	7	a	a	DET
eurjchem-1084	28	8	physiological	physiological	ADJ
eurjchem-1084	28	9	level	level	NOUN
eurjchem-1084	28	10	,	,	PUNCT
eurjchem-1084	28	11	the	the	DET
eurjchem-1084	28	12	body	body	NOUN
eurjchem-1084	28	13	mobilizes	mobilize	VERB
eurjchem-1084	28	14	stored	store	VERB
eurjchem-1084	28	15	sugar	sugar	NOUN
eurjchem-1084	28	16	as	as	ADP
eurjchem-1084	28	17	an	an	DET
eurjchem-1084	28	18	energy	energy	NOUN
eurjchem-1084	28	19	source	source	NOUN
eurjchem-1084	28	20	through	through	ADP
eurjchem-1084	28	21	glycogenolysis	glycogenolysis	NOUN
eurjchem-1084	28	22	,	,	PUNCT
eurjchem-1084	28	23	which	which	PRON
eurjchem-1084	28	24	hydrolyzes	hydrolyze	VERB
eurjchem-1084	28	25	the	the	DET
eurjchem-1084	28	26	glycogen	glycogen	NOUN
eurjchem-1084	28	27	stored	store	VERB
eurjchem-1084	28	28	in	in	ADP
eurjchem-1084	28	29	the	the	DET
eurjchem-1084	28	30	liver	liver	NOUN
eurjchem-1084	28	31	and	and	CCONJ
eurjchem-1084	28	32	muscles	muscle	NOUN
eurjchem-1084	28	33	into	into	ADP
eurjchem-1084	28	34	glucose	glucose	NOUN
eurjchem-1084	28	35	,	,	PUNCT
eurjchem-1084	28	36	which	which	PRON
eurjchem-1084	28	37	can	can	AUX
eurjchem-1084	28	38	then	then	ADV
eurjchem-1084	28	39	be	be	AUX
eurjchem-1084	28	40	used	use	VERB
eurjchem-1084	28	41	as	as	ADP
eurjchem-1084	28	42	an	an	DET
eurjchem-1084	28	43	energy	energy	NOUN
eurjchem-1084	28	44	source	source	NOUN
eurjchem-1084	28	45	[	[	X
eurjchem-1084	28	46	3	3	NUM
eurjchem-1084	28	47	]	]	PUNCT
eurjchem-1084	28	48	.	.	PUNCT
eurjchem-1084	29	1	diabetes	diabetes	NOUN
eurjchem-1084	29	2	mellitus	mellitus	NOUN
eurjchem-1084	29	3	is	be	AUX
eurjchem-1084	29	4	a	a	DET
eurjchem-1084	29	5	systemic	systemic	ADJ
eurjchem-1084	29	6	metabolic	metabolic	NOUN
eurjchem-1084	29	7	disease	disease	NOUN
eurjchem-1084	29	8	described	describe	VERB
eurjchem-1084	29	9	by	by	ADP
eurjchem-1084	29	10	hyperglycemia	hyperglycemia	NOUN
eurjchem-1084	29	11	,	,	PUNCT
eurjchem-1084	29	12	hyperlipidemia	hyperlipidemia	NOUN
eurjchem-1084	29	13	,	,	PUNCT
eurjchem-1084	29	14	hyperaminoacidemia	hyperaminoacidemia	NOUN
eurjchem-1084	29	15	,	,	PUNCT
eurjchem-1084	29	16	and	and	CCONJ
eurjchem-1084	29	17	hypoinsulinaemia	hypoinsulinaemia	NOUN
eurjchem-1084	29	18	that	that	PRON
eurjchem-1084	29	19	leads	lead	VERB
eurjchem-1084	29	20	to	to	ADP
eurjchem-1084	29	21	reduction	reduction	NOUN
eurjchem-1084	29	22	in	in	ADP
eurjchem-1084	29	23	both	both	PRON
eurjchem-1084	29	24	insulin	insulin	NOUN
eurjchem-1084	29	25	secretion	secretion	NOUN
eurjchem-1084	29	26	and	and	CCONJ
eurjchem-1084	29	27	insulin	insulin	NOUN
eurjchem-1084	29	28	action	action	NOUN
eurjchem-1084	29	29	.	.	PUNCT
eurjchem-1084	30	1	it	it	PRON
eurjchem-1084	30	2	is	be	AUX
eurjchem-1084	30	3	often	often	ADV
eurjchem-1084	30	4	linked	link	VERB
eurjchem-1084	30	5	with	with	ADP
eurjchem-1084	30	6	the	the	DET
eurjchem-1084	30	7	development	development	NOUN
eurjchem-1084	30	8	of	of	ADP
eurjchem-1084	30	9	micro	micro	ADJ
eurjchem-1084	30	10	and	and	CCONJ
eurjchem-1084	30	11	macro	macro	ADJ
eurjchem-1084	30	12	vascular	vascular	ADJ
eurjchem-1084	30	13	diseases	disease	NOUN
eurjchem-1084	30	14	,	,	PUNCT
eurjchem-1084	30	15	which	which	PRON
eurjchem-1084	30	16	include	include	VERB
eurjchem-1084	30	17	neuropathy	neuropathy	ADJ
eurjchem-1084	30	18	,	,	PUNCT
eurjchem-1084	30	19	nephropathy	nephropathy	ADJ
eurjchem-1084	30	20	,	,	PUNCT
eurjchem-1084	30	21	cardiovascular	cardiovascular	ADJ
eurjchem-1084	30	22	and	and	CCONJ
eurjchem-1084	30	23	cerebro‐	cerebro‐	NOUN
eurjchem-1084	30	24	vascular	vascular	ADJ
eurjchem-1084	30	25	diseases	disease	NOUN
eurjchem-1084	30	26	.	.	PUNCT
eurjchem-1084	31	1	diabetes	diabetes	NOUN
eurjchem-1084	31	2	mellitus	mellitus	NOUN
eurjchem-1084	31	3	is	be	AUX
eurjchem-1084	31	4	associated	associate	VERB
eurjchem-1084	31	5	with	with	ADP
eurjchem-1084	31	6	reduced	reduced	ADJ
eurjchem-1084	31	7	quality	quality	NOUN
eurjchem-1084	31	8	of	of	ADP
eurjchem-1084	31	9	life	life	NOUN
eurjchem-1084	31	10	and	and	CCONJ
eurjchem-1084	31	11	increased	increase	VERB
eurjchem-1084	31	12	risk	risk	NOUN
eurjchem-1084	31	13	features	feature	NOUN
eurjchem-1084	31	14	for	for	ADP
eurjchem-1084	31	15	mortality	mortality	NOUN
eurjchem-1084	31	16	and	and	CCONJ
eurjchem-1084	31	17	morbidity	morbidity	NOUN
eurjchem-1084	31	18	.	.	PUNCT
eurjchem-1084	32	1	the	the	DET
eurjchem-1084	32	2	longstanding	longstanding	ADJ
eurjchem-1084	32	3	hyperglycemia	hyperglycemia	NOUN
eurjchem-1084	32	4	is	be	AUX
eurjchem-1084	32	5	an	an	DET
eurjchem-1084	32	6	important	important	ADJ
eurjchem-1084	32	7	factor	factor	NOUN
eurjchem-1084	32	8	in	in	ADP
eurjchem-1084	32	9	the	the	DET
eurjchem-1084	32	10	progression	progression	NOUN
eurjchem-1084	32	11	and	and	CCONJ
eurjchem-1084	32	12	development	development	NOUN
eurjchem-1084	32	13	of	of	ADP
eurjchem-1084	32	14	micro‐	micro‐	PRON
eurjchem-1084	32	15	and	and	CCONJ
eurjchem-1084	32	16	macro‐vascular	macro‐vascular	ADJ
eurjchem-1084	32	17	problems	problem	NOUN
eurjchem-1084	32	18	[	[	X
eurjchem-1084	32	19	4	4	NUM
eurjchem-1084	32	20	]	]	PUNCT
eurjchem-1084	32	21	.	.	PUNCT
eurjchem-1084	33	1	this	this	DET
eurjchem-1084	33	2	study	study	NOUN
eurjchem-1084	33	3	was	be	AUX
eurjchem-1084	33	4	performed	perform	VERB
eurjchem-1084	33	5	during	during	ADP
eurjchem-1084	33	6	the	the	DET
eurjchem-1084	33	7	period	period	NOUN
eurjchem-1084	33	8	from	from	ADP
eurjchem-1084	33	9	december	december	PROPN
eurjchem-1084	33	10	2012	2012	NUM
eurjchem-1084	33	11	to	to	ADP
eurjchem-1084	33	12	may	may	PROPN
eurjchem-1084	33	13	2013	2013	NUM
eurjchem-1084	33	14	.	.	PUNCT
eurjchem-1084	34	1	this	this	DET
eurjchem-1084	34	2	study	study	NOUN
eurjchem-1084	34	3	includes	include	VERB
eurjchem-1084	34	4	fifty	fifty	NUM
eurjchem-1084	34	5	patients	patient	NOUN
eurjchem-1084	34	6	with	with	ADP
eurjchem-1084	34	7	diabetes	diabetes	NOUN
eurjchem-1084	34	8	mellitus	mellitus	NOUN
eurjchem-1084	34	9	.	.	PUNCT
eurjchem-1084	35	1	patients	patient	NOUN
eurjchem-1084	35	2	,	,	PUNCT
eurjchem-1084	35	3	with	with	ADP
eurjchem-1084	35	4	range	range	NOUN
eurjchem-1084	35	5	of	of	ADP
eurjchem-1084	35	6	50‐65	50‐65	NUM
eurjchem-1084	35	7	years	year	NOUN
eurjchem-1084	35	8	old	old	ADJ
eurjchem-1084	35	9	,	,	PUNCT
eurjchem-1084	35	10	were	be	AUX
eurjchem-1084	35	11	included	include	VERB
eurjchem-1084	35	12	in	in	ADP
eurjchem-1084	35	13	this	this	DET
eurjchem-1084	35	14	study	study	NOUN
eurjchem-1084	35	15	.	.	PUNCT
eurjchem-1084	36	1	blood	blood	NOUN
eurjchem-1084	36	2	samples	sample	NOUN
eurjchem-1084	36	3	were	be	AUX
eurjchem-1084	36	4	taken	take	VERB
eurjchem-1084	36	5	from	from	ADP
eurjchem-1084	36	6	the	the	DET
eurjchem-1084	36	7	patients	patient	NOUN
eurjchem-1084	36	8	after	after	ADP
eurjchem-1084	36	9	having	having	AUX
eurjchem-1084	36	10	thoroughly	thoroughly	ADV
eurjchem-1084	36	11	examined	examine	VERB
eurjchem-1084	36	12	after	after	ADP
eurjchem-1084	36	13	exclusion	exclusion	NOUN
eurjchem-1084	36	14	of	of	ADP
eurjchem-1084	36	15	subjects	subject	NOUN
eurjchem-1084	36	16	with	with	ADP
eurjchem-1084	36	17	a	a	DET
eurjchem-1084	36	18	history	history	NOUN
eurjchem-1084	36	19	acute	acute	NOUN
eurjchem-1084	36	20	myocardial	myocardial	ADJ
eurjchem-1084	36	21	infarction	infarction	NOUN
eurjchem-1084	36	22	or	or	CCONJ
eurjchem-1084	36	23	any	any	DET
eurjchem-1084	36	24	chronic	chronic	ADJ
eurjchem-1084	36	25	diseases	disease	NOUN
eurjchem-1084	36	26	.	.	PUNCT
eurjchem-1084	37	1	control	control	NOUN
eurjchem-1084	37	2	groups	group	NOUN
eurjchem-1084	37	3	contain	contain	VERB
eurjchem-1084	37	4	forty	forty	NUM
eurjchem-1084	37	5	healthy	healthy	ADJ
eurjchem-1084	37	6	individuals	individual	NOUN
eurjchem-1084	37	7	who	who	PRON
eurjchem-1084	37	8	were	be	AUX
eurjchem-1084	37	9	matched	match	VERB
eurjchem-1084	37	10	for	for	ADP
eurjchem-1084	37	11	age	age	NOUN
eurjchem-1084	37	12	,	,	PUNCT
eurjchem-1084	37	13	sex	sex	NOUN
eurjchem-1084	37	14	and	and	CCONJ
eurjchem-1084	37	15	body	body	NOUN
eurjchem-1084	37	16	mass	mass	NOUN
eurjchem-1084	37	17	index	index	NOUN
eurjchem-1084	37	18	in	in	ADP
eurjchem-1084	37	19	this	this	DET
eurjchem-1084	37	20	study	study	NOUN
eurjchem-1084	37	21	as	as	ADP
eurjchem-1084	37	22	control	control	NOUN
eurjchem-1084	37	23	group	group	NOUN
eurjchem-1084	37	24	.	.	PUNCT
eurjchem-1084	38	1	2	2	X
eurjchem-1084	38	2	.	.	X
eurjchem-1084	38	3	experimental	experimental	ADJ
eurjchem-1084	38	4	2.1	2.1	NUM
eurjchem-1084	38	5	.	.	PUNCT
eurjchem-1084	38	6	blood	blood	NOUN
eurjchem-1084	38	7	collection	collection	NOUN
eurjchem-1084	38	8	and	and	CCONJ
eurjchem-1084	38	9	laboratory	laboratory	NOUN
eurjchem-1084	38	10	analysis	analysis	NOUN
eurjchem-1084	38	11	five	five	NUM
eurjchem-1084	38	12	milliliters	milliliter	NOUN
eurjchem-1084	38	13	of	of	ADP
eurjchem-1084	38	14	intravenous	intravenous	ADJ
eurjchem-1084	38	15	blood	blood	NOUN
eurjchem-1084	38	16	were	be	AUX
eurjchem-1084	38	17	taken	take	VERB
eurjchem-1084	38	18	from	from	ADP
eurjchem-1084	38	19	each	each	DET
eurjchem-1084	38	20	control	control	NOUN
eurjchem-1084	38	21	and	and	CCONJ
eurjchem-1084	38	22	patient	patient	NOUN
eurjchem-1084	38	23	.	.	PUNCT
eurjchem-1084	39	1	530	530	NUM
eurjchem-1084	39	2	ibrahim	ibrahim	PROPN
eurjchem-1084	39	3	/	/	SYM
eurjchem-1084	39	4	european	european	PROPN
eurjchem-1084	39	5	journal	journal	PROPN
eurjchem-1084	39	6	of	of	ADP
eurjchem-1084	39	7	chemistry	chemistry	NOUN
eurjchem-1084	39	8	5	5	NUM
eurjchem-1084	39	9	(	(	PUNCT
eurjchem-1084	39	10	3	3	NUM
eurjchem-1084	39	11	)	)	PUNCT
eurjchem-1084	39	12	(	(	PUNCT
eurjchem-1084	39	13	2014	2014	NUM
eurjchem-1084	39	14	)	)	PUNCT
eurjchem-1084	39	15	529‐531	529‐531	NUM
eurjchem-1084	39	16	table	table	NOUN
eurjchem-1084	39	17	1	1	NUM
eurjchem-1084	39	18	.	.	PUNCT
eurjchem-1084	39	19	comparison	comparison	NOUN
eurjchem-1084	39	20	between	between	ADP
eurjchem-1084	39	21	groups	group	NOUN
eurjchem-1084	39	22	for	for	ADP
eurjchem-1084	39	23	age	age	NOUN
eurjchem-1084	39	24	,	,	PUNCT
eurjchem-1084	39	25	bmi	bmi	PROPN
eurjchem-1084	39	26	,	,	PUNCT
eurjchem-1084	39	27	il‐8	il‐8	PROPN
eurjchem-1084	39	28	,	,	PUNCT
eurjchem-1084	39	29	lipid	lipid	NOUN
eurjchem-1084	39	30	profile	profile	NOUN
eurjchem-1084	39	31	,	,	PUNCT
eurjchem-1084	39	32	glucose	glucose	NOUN
eurjchem-1084	39	33	and	and	CCONJ
eurjchem-1084	39	34	insulin	insulin	NOUN
eurjchem-1084	39	35	.	.	PUNCT
eurjchem-1084	40	1	p‐value	p‐value	DET
eurjchem-1084	40	2	male	male	ADJ
eurjchem-1084	40	3	control	control	NOUN
eurjchem-1084	40	4	(	(	PUNCT
eurjchem-1084	40	5	no	no	NOUN
eurjchem-1084	40	6	=	=	NOUN
eurjchem-1084	40	7	24	24	NUM
eurjchem-1084	40	8	)	)	PUNCT
eurjchem-1084	40	9	male	male	ADJ
eurjchem-1084	40	10	patients	patient	NOUN
eurjchem-1084	40	11	(	(	PUNCT
eurjchem-1084	40	12	no	no	PRON
eurjchem-1084	40	13	=	=	SYM
eurjchem-1084	40	14	34	34	NUM
eurjchem-1084	40	15	)	)	PUNCT
eurjchem-1084	40	16	p‐value	p‐value	DET
eurjchem-1084	40	17	female	female	ADJ
eurjchem-1084	40	18	control	control	NOUN
eurjchem-1084	40	19	(	(	PUNCT
eurjchem-1084	40	20	no	no	PRON
eurjchem-1084	40	21	=	=	NOUN
eurjchem-1084	40	22	16	16	NUM
eurjchem-1084	40	23	)	)	PUNCT
eurjchem-1084	40	24	female	female	ADJ
eurjchem-1084	40	25	patients	patient	NOUN
eurjchem-1084	40	26	(	(	PUNCT
eurjchem-1084	40	27	no	no	PRON
eurjchem-1084	40	28	=	=	NOUN
eurjchem-1084	40	29	16	16	NUM
eurjchem-1084	40	30	)	)	PUNCT
eurjchem-1084	40	31	parameters	parameter	NOUN
eurjchem-1084	40	32	0.90158.76±7.09	0.90158.76±7.09	VERB
eurjchem-1084	41	1	59.34±11.370.86462.45±6.0963.66±12.01	59.34±11.370.86462.45±6.0963.66±12.01	ADJ
eurjchem-1084	41	2	age	age	NOUN
eurjchem-1084	41	3	years	year	NOUN
eurjchem-1084	41	4	˂0.001	˂0.001	VERB
eurjchem-1084	41	5	25.84±10.18	25.84±10.18	NUM
eurjchem-1084	41	6	54.11±22.33	54.11±22.33	NUM
eurjchem-1084	41	7	˂0.001	˂0.001	NOUN
eurjchem-1084	41	8	27.92±7.95	27.92±7.95	NUM
eurjchem-1084	41	9	50.15±16.37	50.15±16.37	NUM
eurjchem-1084	41	10	il‐8	il‐8	NOUN
eurjchem-1084	41	11	,	,	PUNCT
eurjchem-1084	41	12	g	g	NOUN
eurjchem-1084	41	13	/	/	SYM
eurjchem-1084	41	14	ml	ml	NOUN
eurjchem-1084	41	15	˂0.001	˂0.001	VERB
eurjchem-1084	41	16	147.05±12.29	147.05±12.29	NUM
eurjchem-1084	41	17	179.52±23.28	179.52±23.28	NUM
eurjchem-1084	41	18	˂0.001	˂0.001	VERB
eurjchem-1084	41	19	160.81±4.35	160.81±4.35	NUM
eurjchem-1084	41	20	191.70±5.03	191.70±5.03	NUM
eurjchem-1084	41	21	cholesterol	cholesterol	NOUN
eurjchem-1084	41	22	,	,	PUNCT
eurjchem-1084	41	23	mg	mg	PROPN
eurjchem-1084	41	24	/	/	SYM
eurjchem-1084	41	25	dl	dl	PROPN
eurjchem-1084	41	26	˂0.001	˂0.001	VERB
eurjchem-1084	41	27	145.58±6.14	145.58±6.14	NUM
eurjchem-1084	41	28	169.03±4.87	169.03±4.87	NUM
eurjchem-1084	41	29	˂0.001	˂0.001	VERB
eurjchem-1084	41	30	137.22±4.98	137.22±4.98	NUM
eurjchem-1084	41	31	155.86±25.09	155.86±25.09	NUM
eurjchem-1084	41	32	triglycerides	triglyceride	NOUN
eurjchem-1084	41	33	,	,	PUNCT
eurjchem-1084	41	34	mg	mg	PROPN
eurjchem-1084	41	35	/	/	SYM
eurjchem-1084	41	36	dl	dl	PROPN
eurjchem-1084	41	37	˂0.001	˂0.001	VERB
eurjchem-1084	41	38	144.82±7.19	144.82±7.19	NUM
eurjchem-1084	41	39	170.13±3.29	170.13±3.29	NUM
eurjchem-1084	41	40	˂0.001	˂0.001	NOUN
eurjchem-1084	41	41	139.29±5.09	139.29±5.09	NUM
eurjchem-1084	41	42	157.75±19.15	157.75±19.15	NUM
eurjchem-1084	41	43	vldl‐c	vldl‐c	NOUN
eurjchem-1084	41	44	,	,	PUNCT
eurjchem-1084	41	45	mg	mg	PROPN
eurjchem-1084	41	46	/	/	SYM
eurjchem-1084	41	47	dl	dl	PROPN
eurjchem-1084	41	48	˂0.001148.73±16.71	˂0.001148.73±16.71	PROPN
eurjchem-1084	41	49	157.92±22.9˂0.001120.6210.61155.87±5.78	157.92±22.9˂0.001120.6210.61155.87±5.78	NUM
eurjchem-1084	41	50	ldl‐c	ldl‐c	PROPN
eurjchem-1084	41	51	,	,	PUNCT
eurjchem-1084	41	52	mg	mg	PROPN
eurjchem-1084	41	53	/	/	SYM
eurjchem-1084	41	54	dl	dl	PROPN
eurjchem-1084	41	55	˂0.00150.07±10.26	˂0.00150.07±10.26	PROPN
eurjchem-1084	41	56	29.88±5.99˂0.00145.26±9.8235.09±5.83	29.88±5.99˂0.00145.26±9.8235.09±5.83	PROPN
eurjchem-1084	41	57	hdl	hdl	NOUN
eurjchem-1084	41	58	,	,	PUNCT
eurjchem-1084	41	59	mg	mg	PROPN
eurjchem-1084	41	60	/	/	SYM
eurjchem-1084	41	61	dl	dl	PROPN
eurjchem-1084	42	1	0.81125.97±5.01	0.81125.97±5.01	PRON
eurjchem-1084	42	2	29.71±4.790.71326.84±2.7230.90±3.84	29.71±4.790.71326.84±2.7230.90±3.84	PROPN
eurjchem-1084	42	3	bmi	bmi	PROPN
eurjchem-1084	42	4	,	,	PUNCT
eurjchem-1084	42	5	kg	kg	PROPN
eurjchem-1084	42	6	/	/	SYM
eurjchem-1084	42	7	m2	m2	PROPN
eurjchem-1084	42	8	˂0.00195.83±9.27	˂0.00195.83±9.27	PROPN
eurjchem-1084	42	9	213.64±12.11˂0.00190.34±16.42209.87±18.61	213.64±12.11˂0.00190.34±16.42209.87±18.61	PROPN
eurjchem-1084	42	10	glucose	glucose	NOUN
eurjchem-1084	42	11	,	,	PUNCT
eurjchem-1084	42	12	mg	mg	PROPN
eurjchem-1084	42	13	/	/	SYM
eurjchem-1084	42	14	dl	dl	PROPN
eurjchem-1084	42	15	˂0.00130.29±8.12	˂0.00130.29±8.12	NUM
eurjchem-1084	42	16	72.01±7.09˂0.00129.89±7.4770.99±12.03	72.01±7.09˂0.00129.89±7.4770.99±12.03	ADJ
eurjchem-1084	42	17	insulin	insulin	NOUN
eurjchem-1084	42	18	,	,	PUNCT
eurjchem-1084	42	19	iu	iu	ADJ
eurjchem-1084	42	20	/	/	SYM
eurjchem-1084	42	21	ml	ml	NOUN
eurjchem-1084	42	22	table	table	NOUN
eurjchem-1084	42	23	2	2	NUM
eurjchem-1084	42	24	.	.	PUNCT
eurjchem-1084	43	1	the	the	DET
eurjchem-1084	43	2	correlation	correlation	NOUN
eurjchem-1084	43	3	coefficient	coefficient	NOUN
eurjchem-1084	43	4	(	(	PUNCT
eurjchem-1084	43	5	r	r	NOUN
eurjchem-1084	43	6	)	)	PUNCT
eurjchem-1084	43	7	between	between	ADP
eurjchem-1084	43	8	il‐8	il‐8	PRON
eurjchem-1084	43	9	with	with	ADP
eurjchem-1084	43	10	lipid	lipid	NOUN
eurjchem-1084	43	11	profile	profile	NOUN
eurjchem-1084	43	12	,	,	PUNCT
eurjchem-1084	43	13	glucose	glucose	NOUN
eurjchem-1084	43	14	and	and	CCONJ
eurjchem-1084	43	15	insulin	insulin	NOUN
eurjchem-1084	43	16	between	between	ADP
eurjchem-1084	43	17	groups	group	NOUN
eurjchem-1084	43	18	.	.	PUNCT
eurjchem-1084	44	1	correlation	correlation	NOUN
eurjchem-1084	44	2	coefficient	coefficient	NOUN
eurjchem-1084	44	3	,	,	PUNCT
eurjchem-1084	44	4	r	r	NOUN
eurjchem-1084	44	5	(	(	PUNCT
eurjchem-1084	44	6	male	male	ADJ
eurjchem-1084	44	7	patients	patient	NOUN
eurjchem-1084	45	1	no	no	PRON
eurjchem-1084	45	2	=	=	NOUN
eurjchem-1084	45	3	34	34	NUM
eurjchem-1084	45	4	)	)	PUNCT
eurjchem-1084	45	5	correlation	correlation	NOUN
eurjchem-1084	45	6	coefficient	coefficient	NOUN
eurjchem-1084	45	7	,	,	PUNCT
eurjchem-1084	45	8	r	r	NOUN
eurjchem-1084	45	9	(	(	PUNCT
eurjchem-1084	45	10	female	female	ADJ
eurjchem-1084	45	11	patients	patient	NOUN
eurjchem-1084	45	12	no	no	PRON
eurjchem-1084	46	1	=	=	NOUN
eurjchem-1084	46	2	16	16	NUM
eurjchem-1084	46	3	)	)	PUNCT
eurjchem-1084	46	4	parameters	parameter	NOUN
eurjchem-1084	46	5	0.5120.522	0.5120.522	VERB
eurjchem-1084	46	6	cholesterol	cholesterol	NOUN
eurjchem-1084	46	7	0.5030.515	0.5030.515	NOUN
eurjchem-1084	46	8	triglycerides	triglyceride	VERB
eurjchem-1084	46	9	0.5050.514	0.5050.514	NUM
eurjchem-1084	46	10	vldl‐c	vldl‐c	NOUN
eurjchem-1084	46	11	0.426	0.426	NUM
eurjchem-1084	46	12	0.416	0.416	NUM
eurjchem-1084	46	13	ldl‐c	ldl‐c	SYM
eurjchem-1084	46	14	‐0.263‐0.302	‐0.263‐0.302	X
eurjchem-1084	47	1	hdl	hdl	NOUN
eurjchem-1084	48	1	0.324	0.324	NUM
eurjchem-1084	48	2	0.317	0.317	NUM
eurjchem-1084	48	3	ldl	ldl	PROPN
eurjchem-1084	48	4	/	/	SYM
eurjchem-1084	48	5	hdl	hdl	PROPN
eurjchem-1084	48	6	0.501	0.501	NUM
eurjchem-1084	48	7	0.498	0.498	NUM
eurjchem-1084	48	8	bmi	bmi	VERB
eurjchem-1084	48	9	0.358	0.358	NUM
eurjchem-1084	48	10	0.336	0.336	NUM
eurjchem-1084	48	11	glucose	glucose	NOUN
eurjchem-1084	48	12	0.4170.403	0.4170.403	NOUN
eurjchem-1084	48	13	insulin	insulin	NOUN
eurjchem-1084	48	14	these	these	DET
eurjchem-1084	48	15	samples	sample	NOUN
eurjchem-1084	48	16	were	be	AUX
eurjchem-1084	48	17	taken	take	VERB
eurjchem-1084	48	18	from	from	ADP
eurjchem-1084	48	19	fasting	fast	VERB
eurjchem-1084	48	20	persons	person	NOUN
eurjchem-1084	48	21	(	(	PUNCT
eurjchem-1084	48	22	at	at	ADP
eurjchem-1084	48	23	least	least	ADV
eurjchem-1084	48	24	10	10	NUM
eurjchem-1084	48	25	hours	hour	NOUN
eurjchem-1084	48	26	)	)	PUNCT
eurjchem-1084	48	27	between	between	ADP
eurjchem-1084	48	28	8	8	NUM
eurjchem-1084	48	29	a.m.	a.m.	NOUN
eurjchem-1084	48	30	and	and	CCONJ
eurjchem-1084	48	31	9	9	NUM
eurjchem-1084	48	32	a.m.	a.m.	ADV
eurjchem-1084	48	33	,	,	PUNCT
eurjchem-1084	48	34	the	the	DET
eurjchem-1084	48	35	samples	sample	NOUN
eurjchem-1084	48	36	transported	transport	VERB
eurjchem-1084	48	37	to	to	ADP
eurjchem-1084	48	38	plain	plain	ADJ
eurjchem-1084	48	39	tubes	tube	NOUN
eurjchem-1084	48	40	to	to	PART
eurjchem-1084	48	41	determine	determine	VERB
eurjchem-1084	48	42	lipid	lipid	NOUN
eurjchem-1084	48	43	profile	profile	NOUN
eurjchem-1084	48	44	,	,	PUNCT
eurjchem-1084	48	45	insulin	insulin	NOUN
eurjchem-1084	48	46	,	,	PUNCT
eurjchem-1084	48	47	glucose	glucose	NOUN
eurjchem-1084	48	48	and	and	CCONJ
eurjchem-1084	48	49	il‐8	il‐8	NOUN
eurjchem-1084	48	50	.	.	PUNCT
eurjchem-1084	49	1	leaving	leave	VERB
eurjchem-1084	49	2	the	the	DET
eurjchem-1084	49	3	blood	blood	NOUN
eurjchem-1084	49	4	non‐heparinized	non‐heparinize	VERB
eurjchem-1084	49	5	in	in	ADP
eurjchem-1084	49	6	the	the	DET
eurjchem-1084	49	7	tubes	tube	NOUN
eurjchem-1084	49	8	to	to	PART
eurjchem-1084	49	9	be	be	AUX
eurjchem-1084	49	10	clotted	clot	VERB
eurjchem-1084	49	11	.	.	PUNCT
eurjchem-1084	50	1	after	after	ADP
eurjchem-1084	50	2	that	that	PRON
eurjchem-1084	50	3	and	and	CCONJ
eurjchem-1084	50	4	in	in	ADP
eurjchem-1084	50	5	order	order	NOUN
eurjchem-1084	50	6	to	to	PART
eurjchem-1084	50	7	separate	separate	VERB
eurjchem-1084	50	8	the	the	DET
eurjchem-1084	50	9	serum	serum	NOUN
eurjchem-1084	50	10	,	,	PUNCT
eurjchem-1084	50	11	centrifugation	centrifugation	NOUN
eurjchem-1084	50	12	of	of	ADP
eurjchem-1084	50	13	the	the	DET
eurjchem-1084	50	14	sample	sample	NOUN
eurjchem-1084	50	15	was	be	AUX
eurjchem-1084	50	16	conducted	conduct	VERB
eurjchem-1084	50	17	for	for	ADP
eurjchem-1084	50	18	5	5	NUM
eurjchem-1084	50	19	min	min	NOUN
eurjchem-1084	50	20	(	(	PUNCT
eurjchem-1084	50	21	4000	4000	NUM
eurjchem-1084	50	22	rpm	rpm	NOUN
eurjchem-1084	50	23	)	)	PUNCT
eurjchem-1084	50	24	.	.	PUNCT
eurjchem-1084	51	1	1.0	1.0	NUM
eurjchem-1084	51	2	ml	ml	NOUN
eurjchem-1084	51	3	serum	serum	NOUN
eurjchem-1084	51	4	was	be	AUX
eurjchem-1084	51	5	taken	take	VERB
eurjchem-1084	51	6	into	into	ADP
eurjchem-1084	51	7	strongly	strongly	ADV
eurjchem-1084	51	8	closed	close	VERB
eurjchem-1084	51	9	eppendorf	eppendorf	PROPN
eurjchem-1084	51	10	tubes	tube	NOUN
eurjchem-1084	51	11	and	and	CCONJ
eurjchem-1084	51	12	kept	keep	VERB
eurjchem-1084	51	13	at	at	ADP
eurjchem-1084	51	14	‐20	‐20	NOUN
eurjchem-1084	51	15	°	°	ADP
eurjchem-1084	51	16	c	c	NOUN
eurjchem-1084	51	17	until	until	SCONJ
eurjchem-1084	51	18	examined	examine	VERB
eurjchem-1084	51	19	.	.	PUNCT
eurjchem-1084	52	1	to	to	PART
eurjchem-1084	52	2	omit	omit	VERB
eurjchem-1084	52	3	kidney	kidney	NOUN
eurjchem-1084	52	4	diseases	disease	NOUN
eurjchem-1084	52	5	,	,	PUNCT
eurjchem-1084	52	6	urea	urea	NOUN
eurjchem-1084	52	7	and	and	CCONJ
eurjchem-1084	52	8	creatinine	creatinine	NOUN
eurjchem-1084	52	9	were	be	AUX
eurjchem-1084	52	10	analyzed	analyze	VERB
eurjchem-1084	52	11	in	in	ADP
eurjchem-1084	52	12	each	each	DET
eurjchem-1084	52	13	serum	serum	NOUN
eurjchem-1084	52	14	sample	sample	NOUN
eurjchem-1084	52	15	(	(	PUNCT
eurjchem-1084	52	16	table	table	NOUN
eurjchem-1084	52	17	1	1	NUM
eurjchem-1084	52	18	)	)	PUNCT
eurjchem-1084	52	19	.	.	PUNCT
eurjchem-1084	53	1	il‐8	il‐8	PROPN
eurjchem-1084	53	2	and	and	CCONJ
eurjchem-1084	53	3	insulin	insulin	NOUN
eurjchem-1084	53	4	were	be	AUX
eurjchem-1084	53	5	determined	determine	VERB
eurjchem-1084	53	6	by	by	ADP
eurjchem-1084	53	7	using	use	VERB
eurjchem-1084	53	8	elisa	elisa	PROPN
eurjchem-1084	53	9	kits	kit	NOUN
eurjchem-1084	53	10	(	(	PUNCT
eurjchem-1084	53	11	table	table	NOUN
eurjchem-1084	53	12	1	1	NUM
eurjchem-1084	53	13	)	)	PUNCT
eurjchem-1084	53	14	.	.	PUNCT
eurjchem-1084	54	1	2.2	2.2	NUM
eurjchem-1084	54	2	.	.	PUNCT
eurjchem-1084	55	1	statistical	statistical	ADJ
eurjchem-1084	55	2	analysis	analysis	NOUN
eurjchem-1084	55	3	statistical	statistical	ADJ
eurjchem-1084	55	4	analysis	analysis	NOUN
eurjchem-1084	55	5	was	be	AUX
eurjchem-1084	55	6	performed	perform	VERB
eurjchem-1084	55	7	by	by	ADP
eurjchem-1084	55	8	statisticians	statistician	NOUN
eurjchem-1084	55	9	using	use	VERB
eurjchem-1084	55	10	spss	spss	PROPN
eurjchem-1084	55	11	15.01	15.01	NUM
eurjchem-1084	55	12	statistical	statistical	ADJ
eurjchem-1084	55	13	set	set	NOUN
eurjchem-1084	55	14	for	for	ADP
eurjchem-1084	55	15	social	social	ADJ
eurjchem-1084	55	16	sciences	science	NOUN
eurjchem-1084	55	17	and	and	CCONJ
eurjchem-1084	55	18	also	also	ADV
eurjchem-1084	55	19	excel	excel	VERB
eurjchem-1084	55	20	2003	2003	NUM
eurjchem-1084	55	21	.	.	PUNCT
eurjchem-1084	56	1	data	datum	NOUN
eurjchem-1084	56	2	for	for	ADP
eurjchem-1084	56	3	the	the	DET
eurjchem-1084	56	4	experimental	experimental	ADJ
eurjchem-1084	56	5	and	and	CCONJ
eurjchem-1084	56	6	test	test	NOUN
eurjchem-1084	56	7	results	result	NOUN
eurjchem-1084	56	8	were	be	AUX
eurjchem-1084	56	9	expressed	express	VERB
eurjchem-1084	56	10	as	as	ADP
eurjchem-1084	56	11	mean	mean	NOUN
eurjchem-1084	56	12	and	and	CCONJ
eurjchem-1084	56	13	stander	stander	NOUN
eurjchem-1084	56	14	error	error	NOUN
eurjchem-1084	56	15	.	.	PUNCT
eurjchem-1084	57	1	the	the	DET
eurjchem-1084	57	2	relationship	relationship	NOUN
eurjchem-1084	57	3	constant	constant	ADJ
eurjchem-1084	57	4	used	use	VERB
eurjchem-1084	57	5	to	to	PART
eurjchem-1084	57	6	find	find	VERB
eurjchem-1084	57	7	the	the	DET
eurjchem-1084	57	8	connection	connection	NOUN
eurjchem-1084	57	9	among	among	ADP
eurjchem-1084	57	10	the	the	DET
eurjchem-1084	57	11	calculated	calculate	VERB
eurjchem-1084	57	12	markers	marker	NOUN
eurjchem-1084	57	13	used	use	VERB
eurjchem-1084	57	14	a	a	DET
eurjchem-1084	57	15	pearson	pearson	NOUN
eurjchem-1084	57	16	correlation	correlation	NOUN
eurjchem-1084	57	17	.	.	PUNCT
eurjchem-1084	58	1	p‐value	p‐value	NOUN
eurjchem-1084	58	2	of	of	ADP
eurjchem-1084	58	3	≤	≤	NUM
eurjchem-1084	58	4	0.05	0.05	NUM
eurjchem-1084	58	5	was	be	AUX
eurjchem-1084	58	6	taken	take	VERB
eurjchem-1084	58	7	as	as	ADV
eurjchem-1084	58	8	significant	significant	ADJ
eurjchem-1084	58	9	.	.	PUNCT
eurjchem-1084	59	1	3	3	X
eurjchem-1084	59	2	.	.	NOUN
eurjchem-1084	59	3	results	result	NOUN
eurjchem-1084	59	4	and	and	CCONJ
eurjchem-1084	59	5	discussion	discussion	NOUN
eurjchem-1084	59	6	during	during	ADP
eurjchem-1084	59	7	the	the	DET
eurjchem-1084	59	8	last	last	ADJ
eurjchem-1084	59	9	decade	decade	NOUN
eurjchem-1084	59	10	it	it	PRON
eurjchem-1084	59	11	has	have	AUX
eurjchem-1084	59	12	become	become	VERB
eurjchem-1084	59	13	more	more	ADV
eurjchem-1084	59	14	and	and	CCONJ
eurjchem-1084	59	15	more	more	ADV
eurjchem-1084	59	16	clear	clear	ADJ
eurjchem-1084	59	17	that	that	SCONJ
eurjchem-1084	59	18	the	the	DET
eurjchem-1084	59	19	adipose	adipose	ADJ
eurjchem-1084	59	20	tissue	tissue	NOUN
eurjchem-1084	59	21	itself	itself	PRON
eurjchem-1084	59	22	synthesizes	synthesize	VERB
eurjchem-1084	59	23	and	and	CCONJ
eurjchem-1084	59	24	releases	release	VERB
eurjchem-1084	59	25	a	a	DET
eurjchem-1084	59	26	group	group	NOUN
eurjchem-1084	59	27	of	of	ADP
eurjchem-1084	59	28	cytokines	cytokine	NOUN
eurjchem-1084	59	29	and	and	CCONJ
eurjchem-1084	59	30	hormone‐like	hormone‐like	ADJ
eurjchem-1084	59	31	proteins	protein	NOUN
eurjchem-1084	59	32	such	such	ADJ
eurjchem-1084	59	33	as	as	ADP
eurjchem-1084	59	34	interleukin‐6	interleukin‐6	NOUN
eurjchem-1084	59	35	(	(	PUNCT
eurjchem-1084	59	36	il‐	il‐	NOUN
eurjchem-1084	59	37	6	6	NUM
eurjchem-1084	59	38	)	)	PUNCT
eurjchem-1084	60	1	[	[	X
eurjchem-1084	60	2	5	5	NUM
eurjchem-1084	60	3	]	]	PUNCT
eurjchem-1084	60	4	,	,	PUNCT
eurjchem-1084	60	5	tumor	tumor	NOUN
eurjchem-1084	60	6	necrosis	necrosis	NOUN
eurjchem-1084	60	7	factor‐α	factor‐α	NOUN
eurjchem-1084	60	8	(	(	PUNCT
eurjchem-1084	60	9	tnf‐α	tnf‐α	NOUN
eurjchem-1084	60	10	)	)	PUNCT
eurjchem-1084	61	1	[	[	X
eurjchem-1084	61	2	6	6	NUM
eurjchem-1084	61	3	]	]	PUNCT
eurjchem-1084	61	4	,	,	PUNCT
eurjchem-1084	61	5	leptin	leptin	NOUN
eurjchem-1084	61	6	,	,	PUNCT
eurjchem-1084	61	7	plasminogen	plasminogen	NOUN
eurjchem-1084	61	8	activator	activator	NOUN
eurjchem-1084	61	9	inhibitor‐1	inhibitor‐1	NOUN
eurjchem-1084	61	10	and	and	CCONJ
eurjchem-1084	61	11	adiponectin	adiponectin	VERB
eurjchem-1084	62	1	[	[	X
eurjchem-1084	62	2	7	7	NUM
eurjchem-1084	62	3	]	]	PUNCT
eurjchem-1084	62	4	,	,	PUNCT
eurjchem-1084	62	5	all	all	PRON
eurjchem-1084	62	6	of	of	ADP
eurjchem-1084	62	7	which	which	PRON
eurjchem-1084	62	8	may	may	AUX
eurjchem-1084	62	9	be	be	AUX
eurjchem-1084	62	10	of	of	ADP
eurjchem-1084	62	11	importance	importance	NOUN
eurjchem-1084	62	12	for	for	ADP
eurjchem-1084	62	13	the	the	DET
eurjchem-1084	62	14	association	association	NOUN
eurjchem-1084	62	15	between	between	ADP
eurjchem-1084	62	16	obesity	obesity	NOUN
eurjchem-1084	62	17	and	and	CCONJ
eurjchem-1084	62	18	health	health	NOUN
eurjchem-1084	62	19	problems	problem	NOUN
eurjchem-1084	62	20	as	as	SCONJ
eurjchem-1084	62	21	shown	show	VERB
eurjchem-1084	62	22	in	in	ADP
eurjchem-1084	62	23	table	table	NOUN
eurjchem-1084	62	24	2	2	NUM
eurjchem-1084	62	25	,	,	PUNCT
eurjchem-1084	62	26	the	the	DET
eurjchem-1084	62	27	positive	positive	ADJ
eurjchem-1084	62	28	correlation	correlation	NOUN
eurjchem-1084	62	29	between	between	ADP
eurjchem-1084	62	30	il‐8	il‐8	PROPN
eurjchem-1084	62	31	and	and	CCONJ
eurjchem-1084	62	32	body	body	NOUN
eurjchem-1084	62	33	mass	mass	NOUN
eurjchem-1084	62	34	index	index	NOUN
eurjchem-1084	62	35	(	(	PUNCT
eurjchem-1084	62	36	bmi	bmi	PROPN
eurjchem-1084	62	37	)	)	PUNCT
eurjchem-1084	62	38	.	.	PUNCT
eurjchem-1084	63	1	it	it	PRON
eurjchem-1084	63	2	has	have	AUX
eurjchem-1084	63	3	lately	lately	ADV
eurjchem-1084	63	4	been	be	AUX
eurjchem-1084	63	5	revealed	reveal	VERB
eurjchem-1084	63	6	by	by	ADP
eurjchem-1084	63	7	bruun	bruun	PROPN
eurjchem-1084	63	8	et	et	PROPN
eurjchem-1084	63	9	al	al	PROPN
eurjchem-1084	63	10	.	.	PROPN
eurjchem-1084	63	11	,	,	PUNCT
eurjchem-1084	64	1	[	[	X
eurjchem-1084	64	2	7	7	X
eurjchem-1084	64	3	]	]	PUNCT
eurjchem-1084	64	4	as	as	ADV
eurjchem-1084	64	5	well	well	ADV
eurjchem-1084	64	6	as	as	ADP
eurjchem-1084	64	7	by	by	ADP
eurjchem-1084	64	8	gerhardt	gerhardt	ADJ
eurjchem-1084	64	9	and	and	CCONJ
eurjchem-1084	64	10	coworkers	coworker	NOUN
eurjchem-1084	64	11	[	[	X
eurjchem-1084	64	12	8	8	NUM
eurjchem-1084	64	13	]	]	PUNCT
eurjchem-1084	64	14	that	that	SCONJ
eurjchem-1084	64	15	il‐8	il‐8	PROPN
eurjchem-1084	64	16	is	be	AUX
eurjchem-1084	64	17	produced	produce	VERB
eurjchem-1084	64	18	and	and	CCONJ
eurjchem-1084	64	19	released	release	VERB
eurjchem-1084	64	20	from	from	ADP
eurjchem-1084	64	21	human	human	ADJ
eurjchem-1084	64	22	mature	mature	NOUN
eurjchem-1084	64	23	isolated	isolate	VERB
eurjchem-1084	64	24	adipocytes	adipocyte	NOUN
eurjchem-1084	64	25	as	as	ADV
eurjchem-1084	64	26	well	well	ADV
eurjchem-1084	64	27	as	as	ADP
eurjchem-1084	64	28	from	from	ADP
eurjchem-1084	64	29	cultured	cultured	ADJ
eurjchem-1084	64	30	human	human	ADJ
eurjchem-1084	64	31	adipose	adipose	NOUN
eurjchem-1084	64	32	tissue	tissue	NOUN
eurjchem-1084	64	33	fragments	fragment	NOUN
eurjchem-1084	64	34	in	in	ADP
eurjchem-1084	64	35	a	a	DET
eurjchem-1084	64	36	regulated	regulated	ADJ
eurjchem-1084	64	37	manner	manner	NOUN
eurjchem-1084	64	38	.	.	PUNCT
eurjchem-1084	65	1	interleukin‐8	interleukin‐8	X
eurjchem-1084	65	2	in	in	ADP
eurjchem-1084	65	3	addition	addition	NOUN
eurjchem-1084	65	4	to	to	ADP
eurjchem-1084	65	5	its	its	PRON
eurjchem-1084	65	6	association	association	NOUN
eurjchem-1084	65	7	with	with	ADP
eurjchem-1084	65	8	a	a	DET
eurjchem-1084	65	9	number	number	NOUN
eurjchem-1084	65	10	of	of	ADP
eurjchem-1084	65	11	inflammatory	inflammatory	ADJ
eurjchem-1084	65	12	processes	process	NOUN
eurjchem-1084	65	13	,	,	PUNCT
eurjchem-1084	65	14	recently	recently	ADV
eurjchem-1084	65	15	been	be	AUX
eurjchem-1084	65	16	implicated	implicate	VERB
eurjchem-1084	65	17	in	in	ADP
eurjchem-1084	65	18	the	the	DET
eurjchem-1084	65	19	pathogenesis	pathogenesis	NOUN
eurjchem-1084	65	20	of	of	ADP
eurjchem-1084	65	21	atherosclerosis	atherosclerosis	NOUN
eurjchem-1084	65	22	[	[	X
eurjchem-1084	65	23	9	9	NUM
eurjchem-1084	65	24	]	]	PUNCT
eurjchem-1084	65	25	.	.	PUNCT
eurjchem-1084	66	1	study	study	NOUN
eurjchem-1084	66	2	by	by	ADP
eurjchem-1084	66	3	kopelman	kopelman	NOUN
eurjchem-1084	66	4	,	,	PUNCT
eurjchem-1084	66	5	p.	p.	PROPN
eurjchem-1084	66	6	g.	g.	PROPN
eurjchem-1084	66	7	reported	report	VERB
eurjchem-1084	66	8	that	that	SCONJ
eurjchem-1084	66	9	il‐8	il‐8	PROPN
eurjchem-1084	66	10	was	be	AUX
eurjchem-1084	66	11	increased	increase	VERB
eurjchem-1084	66	12	in	in	ADP
eurjchem-1084	66	13	obese	obese	ADJ
eurjchem-1084	66	14	subjects	subject	NOUN
eurjchem-1084	66	15	,	,	PUNCT
eurjchem-1084	66	16	and	and	CCONJ
eurjchem-1084	66	17	weight	weight	NOUN
eurjchem-1084	66	18	loss	loss	NOUN
eurjchem-1084	66	19	was	be	AUX
eurjchem-1084	66	20	not	not	PART
eurjchem-1084	66	21	associated	associate	VERB
eurjchem-1084	66	22	with	with	ADP
eurjchem-1084	66	23	a	a	DET
eurjchem-1084	66	24	decrement	decrement	NOUN
eurjchem-1084	66	25	in	in	ADP
eurjchem-1084	66	26	the	the	DET
eurjchem-1084	66	27	circulating	circulate	VERB
eurjchem-1084	66	28	level	level	NOUN
eurjchem-1084	66	29	of	of	ADP
eurjchem-1084	66	30	il‐8	il‐8	NOUN
eurjchem-1084	67	1	[	[	X
eurjchem-1084	67	2	10	10	NUM
eurjchem-1084	67	3	]	]	PUNCT
eurjchem-1084	67	4	.	.	PUNCT
eurjchem-1084	68	1	conversely	conversely	ADV
eurjchem-1084	68	2	,	,	PUNCT
eurjchem-1084	68	3	reports	report	NOUN
eurjchem-1084	68	4	have	have	AUX
eurjchem-1084	68	5	previously	previously	ADV
eurjchem-1084	68	6	demonstrated	demonstrate	VERB
eurjchem-1084	68	7	that	that	SCONJ
eurjchem-1084	68	8	changes	change	NOUN
eurjchem-1084	68	9	in	in	ADP
eurjchem-1084	68	10	the	the	DET
eurjchem-1084	68	11	circulating	circulate	VERB
eurjchem-1084	68	12	levels	level	NOUN
eurjchem-1084	68	13	of	of	ADP
eurjchem-1084	68	14	il‐8	il‐8	PROPN
eurjchem-1084	68	15	after	after	SCONJ
eurjchem-1084	68	16	weight	weight	NOUN
eurjchem-1084	68	17	loss	loss	NOUN
eurjchem-1084	68	18	were	be	AUX
eurjchem-1084	68	19	paralleled	parallel	VERB
eurjchem-1084	68	20	by	by	ADP
eurjchem-1084	68	21	changes	change	NOUN
eurjchem-1084	68	22	in	in	ADP
eurjchem-1084	68	23	adipose	adipose	PRON
eurjchem-1084	68	24	tissue	tissue	NOUN
eurjchem-1084	68	25	levels	level	NOUN
eurjchem-1084	68	26	of	of	ADP
eurjchem-1084	68	27	il‐8	il‐8	PROPN
eurjchem-1084	69	1	[	[	X
eurjchem-1084	69	2	11	11	NUM
eurjchem-1084	69	3	]	]	PUNCT
eurjchem-1084	69	4	.	.	PUNCT
eurjchem-1084	70	1	these	these	DET
eurjchem-1084	70	2	new	new	ADJ
eurjchem-1084	70	3	findings	finding	NOUN
eurjchem-1084	70	4	are	be	AUX
eurjchem-1084	70	5	of	of	ADP
eurjchem-1084	70	6	interest	interest	NOUN
eurjchem-1084	70	7	since	since	SCONJ
eurjchem-1084	70	8	chemokine	chemokine	ADJ
eurjchem-1084	70	9	such	such	ADJ
eurjchem-1084	70	10	as	as	ADP
eurjchem-1084	70	11	il‐8	il‐8	PROPN
eurjchem-1084	70	12	have	have	AUX
eurjchem-1084	70	13	been	be	AUX
eurjchem-1084	70	14	suggested	suggest	VERB
eurjchem-1084	70	15	to	to	PART
eurjchem-1084	70	16	be	be	AUX
eurjchem-1084	70	17	involved	involve	VERB
eurjchem-1084	70	18	in	in	ADP
eurjchem-1084	70	19	the	the	DET
eurjchem-1084	70	20	pathogenesis	pathogenesis	NOUN
eurjchem-1084	70	21	of	of	ADP
eurjchem-1084	70	22	diseases	disease	NOUN
eurjchem-1084	70	23	associated	associate	VERB
eurjchem-1084	70	24	with	with	ADP
eurjchem-1084	70	25	excess	excess	ADJ
eurjchem-1084	70	26	amounts	amount	NOUN
eurjchem-1084	70	27	of	of	ADP
eurjchem-1084	70	28	adipose	adipose	ADJ
eurjchem-1084	70	29	tissue	tissue	NOUN
eurjchem-1084	70	30	e.g.	e.g.	ADJ
eurjchem-1084	70	31	atherosclerosis	atherosclerosis	NOUN
eurjchem-1084	70	32	and	and	CCONJ
eurjchem-1084	70	33	cardiovascular	cardiovascular	ADJ
eurjchem-1084	70	34	disease	disease	NOUN
eurjchem-1084	71	1	[	[	X
eurjchem-1084	71	2	9	9	NUM
eurjchem-1084	71	3	]	]	PUNCT
eurjchem-1084	71	4	.	.	PUNCT
eurjchem-1084	72	1	gerszten	gerszten	VERB
eurjchem-1084	72	2	et	et	PROPN
eurjchem-1084	72	3	al	al	PROPN
eurjchem-1084	72	4	.	.	PROPN
eurjchem-1084	72	5	,	,	PUNCT
eurjchem-1084	73	1	[	[	X
eurjchem-1084	73	2	12	12	NUM
eurjchem-1084	73	3	]	]	PUNCT
eurjchem-1084	73	4	reported	report	VERB
eurjchem-1084	73	5	that	that	SCONJ
eurjchem-1084	73	6	il‐8	il‐8	PROPN
eurjchem-1084	73	7	stimulate	stimulate	VERB
eurjchem-1084	73	8	the	the	DET
eurjchem-1084	73	9	monocyte	monocyte	NOUN
eurjchem-1084	73	10	recruitment	recruitment	NOUN
eurjchem-1084	73	11	and	and	CCONJ
eurjchem-1084	73	12	fixed	fix	VERB
eurjchem-1084	73	13	it	it	PRON
eurjchem-1084	73	14	's	be	AUX
eurjchem-1084	73	15	adhesion	adhesion	NOUN
eurjchem-1084	73	16	to	to	ADP
eurjchem-1084	73	17	endothelium	endothelium	NOUN
eurjchem-1084	73	18	and	and	CCONJ
eurjchem-1084	73	19	thus	thus	ADV
eurjchem-1084	73	20	il‐8	il‐8	PROPN
eurjchem-1084	73	21	contributed	contribute	VERB
eurjchem-1084	73	22	in	in	ADP
eurjchem-1084	73	23	plaque	plaque	NOUN
eurjchem-1084	73	24	formation	formation	NOUN
eurjchem-1084	73	25	.	.	PUNCT
eurjchem-1084	74	1	ley	ley	NOUN
eurjchem-1084	74	2	and	and	CCONJ
eurjchem-1084	74	3	colleagues	colleague	NOUN
eurjchem-1084	75	1	[	[	X
eurjchem-1084	75	2	13	13	NUM
eurjchem-1084	75	3	]	]	PUNCT
eurjchem-1084	75	4	have	have	AUX
eurjchem-1084	75	5	identified	identify	VERB
eurjchem-1084	75	6	the	the	DET
eurjchem-1084	75	7	chemokine	chemokine	ADJ
eurjchem-1084	75	8	kc	kc	PROPN
eurjchem-1084	75	9	(	(	PUNCT
eurjchem-1084	75	10	the	the	DET
eurjchem-1084	75	11	mouse	mouse	NOUN
eurjchem-1084	75	12	homolog	homolog	NOUN
eurjchem-1084	75	13	of	of	ADP
eurjchem-1084	75	14	il‐8	il‐8	PROPN
eurjchem-1084	75	15	)	)	PUNCT
eurjchem-1084	75	16	as	as	ADP
eurjchem-1084	75	17	being	be	AUX
eurjchem-1084	75	18	the	the	DET
eurjchem-1084	75	19	main	main	ADJ
eurjchem-1084	75	20	chemokine	chemokine	NOUN
eurjchem-1084	75	21	that	that	PRON
eurjchem-1084	75	22	triggers	trigger	VERB
eurjchem-1084	75	23	monocyte	monocyte	NOUN
eurjchem-1084	75	24	capture	capture	NOUN
eurjchem-1084	75	25	in	in	ADP
eurjchem-1084	75	26	carotid	carotid	NOUN
eurjchem-1084	75	27	arteries	artery	NOUN
eurjchem-1084	75	28	with	with	ADP
eurjchem-1084	75	29	early	early	ADJ
eurjchem-1084	75	30	atherosclerotic	atherosclerotic	ADJ
eurjchem-1084	75	31	lesions	lesion	NOUN
eurjchem-1084	75	32	.	.	PUNCT
eurjchem-1084	76	1	both	both	PRON
eurjchem-1084	76	2	mildly	mildly	ADV
eurjchem-1084	76	3	oxidized	oxidize	VERB
eurjchem-1084	76	4	low	low	ADJ
eurjchem-1084	76	5	density	density	NOUN
eurjchem-1084	76	6	lipoprotein	lipoprotein	ADJ
eurjchem-1084	76	7	(	(	PUNCT
eurjchem-1084	76	8	ldl	ldl	NOUN
eurjchem-1084	76	9	)	)	PUNCT
eurjchem-1084	76	10	,	,	PUNCT
eurjchem-1084	76	11	and	and	CCONJ
eurjchem-1084	76	12	tnf‐α	tnf‐α	NUM
eurjchem-1084	76	13	can	can	AUX
eurjchem-1084	76	14	induce	induce	VERB
eurjchem-1084	76	15	il‐8	il‐8	PROPN
eurjchem-1084	76	16	mrna	mrna	NOUN
eurjchem-1084	76	17	in	in	ADP
eurjchem-1084	76	18	endothelial	endothelial	ADJ
eurjchem-1084	76	19	cells	cell	NOUN
eurjchem-1084	76	20	[	[	X
eurjchem-1084	76	21	14	14	NUM
eurjchem-1084	76	22	]	]	PUNCT
eurjchem-1084	76	23	.	.	PUNCT
eurjchem-1084	77	1	an	an	DET
eurjchem-1084	77	2	increase	increase	NOUN
eurjchem-1084	77	3	in	in	ADP
eurjchem-1084	77	4	circulating	circulate	VERB
eurjchem-1084	77	5	level	level	NOUN
eurjchem-1084	77	6	of	of	ADP
eurjchem-1084	77	7	il‐8	il‐8	PROPN
eurjchem-1084	77	8	can	can	AUX
eurjchem-1084	77	9	lead	lead	VERB
eurjchem-1084	77	10	to	to	ADP
eurjchem-1084	77	11	increased	increase	VERB
eurjchem-1084	77	12	insulin	insulin	NOUN
eurjchem-1084	77	13	resistance	resistance	NOUN
eurjchem-1084	77	14	,	,	PUNCT
eurjchem-1084	77	15	vascular	vascular	ADJ
eurjchem-1084	77	16	inflammation	inflammation	NOUN
eurjchem-1084	77	17	,	,	PUNCT
eurjchem-1084	77	18	and	and	CCONJ
eurjchem-1084	77	19	the	the	DET
eurjchem-1084	77	20	development	development	NOUN
eurjchem-1084	77	21	of	of	ADP
eurjchem-1084	77	22	vascular	vascular	ADJ
eurjchem-1084	77	23	disease	disease	NOUN
eurjchem-1084	77	24	[	[	X
eurjchem-1084	77	25	15	15	NUM
eurjchem-1084	77	26	]	]	PUNCT
eurjchem-1084	77	27	.	.	PUNCT
eurjchem-1084	78	1	in	in	ADP
eurjchem-1084	78	2	addition	addition	NOUN
eurjchem-1084	78	3	,	,	PUNCT
eurjchem-1084	78	4	it	it	PRON
eurjchem-1084	78	5	has	have	AUX
eurjchem-1084	78	6	been	be	AUX
eurjchem-1084	78	7	reported	report	VERB
eurjchem-1084	78	8	''	''	PUNCT
eurjchem-1084	78	9	that	that	SCONJ
eurjchem-1084	78	10	serum	serum	NOUN
eurjchem-1084	78	11	levels	level	NOUN
eurjchem-1084	78	12	as	as	ADV
eurjchem-1084	78	13	well	well	ADV
eurjchem-1084	78	14	as	as	ADP
eurjchem-1084	78	15	urinary	urinary	ADJ
eurjchem-1084	78	16	levels	level	NOUN
eurjchem-1084	78	17	of	of	ADP
eurjchem-1084	78	18	il‐	il‐	PROPN
eurjchem-1084	78	19	8	8	NUM
eurjchem-1084	78	20	were	be	AUX
eurjchem-1084	78	21	significantly	significantly	ADV
eurjchem-1084	78	22	increased	increase	VERB
eurjchem-1084	78	23	in	in	ADP
eurjchem-1084	78	24	patients	patient	NOUN
eurjchem-1084	78	25	with	with	ADP
eurjchem-1084	78	26	type	type	NOUN
eurjchem-1084	78	27	2	2	NUM
eurjchem-1084	78	28	diabetes	diabetes	NOUN
eurjchem-1084	78	29	with	with	ADP
eurjchem-1084	78	30	and	and	CCONJ
eurjchem-1084	78	31	without	without	ADP
eurjchem-1084	78	32	nephropathy	nephropathy	NOUN
eurjchem-1084	78	33	''	''	PUNCT
eurjchem-1084	79	1	[	[	X
eurjchem-1084	79	2	16	16	NUM
eurjchem-1084	79	3	]	]	PUNCT
eurjchem-1084	79	4	.	.	PUNCT
eurjchem-1084	80	1	atherosclerosis	atherosclerosis	NOUN
eurjchem-1084	80	2	is	be	AUX
eurjchem-1084	80	3	a	a	DET
eurjchem-1084	80	4	foremost	foremost	ADJ
eurjchem-1084	80	5	risk	risk	NOUN
eurjchem-1084	80	6	factor	factor	NOUN
eurjchem-1084	80	7	of	of	ADP
eurjchem-1084	80	8	type	type	NOUN
eurjchem-1084	80	9	2	2	NUM
eurjchem-1084	80	10	diabetes	diabetes	NOUN
eurjchem-1084	80	11	.	.	PUNCT
eurjchem-1084	81	1	endothelial	endothelial	ADJ
eurjchem-1084	81	2	activation	activation	NOUN
eurjchem-1084	81	3	to	to	PART
eurjchem-1084	81	4	bind	bind	VERB
eurjchem-1084	81	5	monocytes	monocyte	NOUN
eurjchem-1084	81	6	is	be	AUX
eurjchem-1084	81	7	a	a	DET
eurjchem-1084	81	8	key	key	ADJ
eurjchem-1084	81	9	early	early	ADJ
eurjchem-1084	81	10	event	event	NOUN
eurjchem-1084	81	11	in	in	ADP
eurjchem-1084	81	12	these	these	DET
eurjchem-1084	81	13	processes	process	NOUN
eurjchem-1084	81	14	.	.	PUNCT
eurjchem-1084	82	1	the	the	DET
eurjchem-1084	82	2	increase	increase	NOUN
eurjchem-1084	82	3	in	in	ADP
eurjchem-1084	82	4	il‐8	il‐8	PROPN
eurjchem-1084	82	5	production	production	NOUN
eurjchem-1084	82	6	seemed	seem	VERB
eurjchem-1084	82	7	to	to	PART
eurjchem-1084	82	8	be	be	AUX
eurjchem-1084	82	9	regulated	regulate	VERB
eurjchem-1084	82	10	at	at	ADP
eurjchem-1084	82	11	the	the	DET
eurjchem-1084	82	12	transcriptional	transcriptional	ADJ
eurjchem-1084	82	13	level	level	NOUN
eurjchem-1084	82	14	,	,	PUNCT
eurjchem-1084	82	15	suseela	suseela	PROPN
eurjchem-1084	82	16	et	et	PROPN
eurjchem-1084	82	17	al	al	PROPN
eurjchem-1084	82	18	.	.	PROPN
eurjchem-1084	82	19	,	,	PUNCT
eurjchem-1084	83	1	[	[	X
eurjchem-1084	83	2	1	1	X
eurjchem-1084	83	3	]	]	PUNCT
eurjchem-1084	83	4	have	have	AUX
eurjchem-1084	83	5	found	find	VERB
eurjchem-1084	83	6	that	that	SCONJ
eurjchem-1084	83	7	glucose	glucose	NOUN
eurjchem-1084	83	8	triggered	trigger	VERB
eurjchem-1084	83	9	il‐8	il‐8	PROPN
eurjchem-1084	83	10	production	production	NOUN
eurjchem-1084	83	11	through	through	ADP
eurjchem-1084	83	12	ap‐1	ap‐1	PROPN
eurjchem-1084	83	13	and	and	CCONJ
eurjchem-1084	83	14	cho‐re	cho‐re	PROPN
eurjchem-1084	83	15	binding	bind	VERB
eurjchem-1084	83	16	elements	element	NOUN
eurjchem-1084	83	17	located	locate	VERB
eurjchem-1084	83	18	within	within	ADP
eurjchem-1084	83	19	the	the	DET
eurjchem-1084	83	20	human	human	PROPN
eurjchem-1084	83	21	il‐8	il‐8	PROPN
eurjchem-1084	83	22	promoter	promoter	NOUN
eurjchem-1084	83	23	,	,	PUNCT
eurjchem-1084	83	24	which	which	PRON
eurjchem-1084	83	25	in	in	ADP
eurjchem-1084	83	26	turn	turn	NOUN
eurjchem-1084	83	27	,	,	PUNCT
eurjchem-1084	83	28	enhance	enhance	VERB
eurjchem-1084	83	29	monocyte	monocyte	NOUN
eurjchem-1084	83	30	:	:	PUNCT
eurjchem-1084	83	31	endothelial	endothelial	ADJ
eurjchem-1084	83	32	interactions	interaction	NOUN
eurjchem-1084	83	33	.	.	PUNCT
eurjchem-1084	84	1	stimula‐	stimula‐	NOUN
eurjchem-1084	84	2	tingly	tingly	ADV
eurjchem-1084	84	3	,	,	PUNCT
eurjchem-1084	84	4	il‐8	il‐8	PROPN
eurjchem-1084	84	5	may	may	AUX
eurjchem-1084	84	6	have	have	VERB
eurjchem-1084	84	7	multiple	multiple	ADJ
eurjchem-1084	84	8	roles	role	NOUN
eurjchem-1084	84	9	in	in	ADP
eurjchem-1084	84	10	mediating	mediate	VERB
eurjchem-1084	84	11	monocyte	monocyte	NOUN
eurjchem-1084	84	12	:	:	PUNCT
eurjchem-1084	84	13	endothelial	endothelial	ADJ
eurjchem-1084	84	14	interactions	interaction	NOUN
eurjchem-1084	84	15	.	.	PUNCT
eurjchem-1084	85	1	first	first	ADV
eurjchem-1084	85	2	,	,	PUNCT
eurjchem-1084	85	3	as	as	ADP
eurjchem-1084	85	4	a	a	DET
eurjchem-1084	85	5	secreted	secreted	ADJ
eurjchem-1084	85	6	chemokine	chemokine	ADJ
eurjchem-1084	85	7	,	,	PUNCT
eurjchem-1084	85	8	it	it	PRON
eurjchem-1084	85	9	signals	signal	VERB
eurjchem-1084	85	10	recruitment	recruitment	NOUN
eurjchem-1084	85	11	of	of	ADP
eurjchem-1084	85	12	monocytes	monocyte	NOUN
eurjchem-1084	85	13	[	[	X
eurjchem-1084	85	14	12	12	NUM
eurjchem-1084	85	15	]	]	PUNCT
eurjchem-1084	85	16	.	.	PUNCT
eurjchem-1084	86	1	the	the	DET
eurjchem-1084	86	2	studies	study	NOUN
eurjchem-1084	86	3	of	of	ADP
eurjchem-1084	86	4	gerszten	gerszten	NOUN
eurjchem-1084	86	5	and	and	CCONJ
eurjchem-1084	86	6	colleagues	colleague	NOUN
eurjchem-1084	86	7	[	[	X
eurjchem-1084	86	8	12	12	NUM
eurjchem-1084	86	9	]	]	PUNCT
eurjchem-1084	86	10	illustrated	illustrate	VERB
eurjchem-1084	86	11	a	a	DET
eurjchem-1084	86	12	new	new	ADJ
eurjchem-1084	86	13	role	role	NOUN
eurjchem-1084	86	14	for	for	ADP
eurjchem-1084	86	15	il‐8	il‐8	PRON
eurjchem-1084	86	16	in	in	ADP
eurjchem-1084	86	17	mediating	mediate	VERB
eurjchem-1084	86	18	monocyte	monocyte	NOUN
eurjchem-1084	86	19	rolling	rolling	NOUN
eurjchem-1084	86	20	,	,	PUNCT
eurjchem-1084	86	21	and	and	CCONJ
eurjchem-1084	86	22	the	the	DET
eurjchem-1084	86	23	recent	recent	ADJ
eurjchem-1084	86	24	elegant	elegant	ADJ
eurjchem-1084	86	25	studies	study	NOUN
eurjchem-1084	86	26	of	of	ADP
eurjchem-1084	86	27	ley	ley	NOUN
eurjchem-1084	86	28	and	and	CCONJ
eurjchem-1084	86	29	colleagues	colleague	NOUN
eurjchem-1084	86	30	[	[	X
eurjchem-1084	86	31	13	13	NUM
eurjchem-1084	86	32	]	]	PUNCT
eurjchem-1084	86	33	implicated	implicated	ADJ
eurjchem-1084	86	34	kc	kc	PROPN
eurjchem-1084	86	35	,	,	PUNCT
eurjchem-1084	86	36	the	the	DET
eurjchem-1084	86	37	murine	murine	ADJ
eurjchem-1084	86	38	homolog	homolog	NOUN
eurjchem-1084	86	39	of	of	ADP
eurjchem-1084	86	40	il‐8	il‐8	PROPN
eurjchem-1084	86	41	,	,	PUNCT
eurjchem-1084	86	42	as	as	ADP
eurjchem-1084	86	43	being	be	AUX
eurjchem-1084	86	44	the	the	DET
eurjchem-1084	86	45	primary	primary	ADJ
eurjchem-1084	86	46	regulator	regulator	NOUN
eurjchem-1084	86	47	of	of	ADP
eurjchem-1084	86	48	monocyte	monocyte	NOUN
eurjchem-1084	86	49	capture	capture	NOUN
eurjchem-1084	86	50	in	in	ADP
eurjchem-1084	86	51	athero‐	athero‐	PUNCT
eurjchem-1084	86	52	sclerotic	sclerotic	ADJ
eurjchem-1084	86	53	carotid	carotid	NOUN
eurjchem-1084	86	54	arteries	artery	NOUN
eurjchem-1084	86	55	.	.	PUNCT
eurjchem-1084	87	1	ley	ley	NOUN
eurjchem-1084	87	2	and	and	CCONJ
eurjchem-1084	87	3	colleagues	colleague	NOUN
eurjchem-1084	87	4	found	find	VERB
eurjchem-1084	87	5	that	that	SCONJ
eurjchem-1084	87	6	kc	kc	PROPN
eurjchem-1084	87	7	was	be	AUX
eurjchem-1084	87	8	more	more	ADV
eurjchem-1084	87	9	important	important	ADJ
eurjchem-1084	87	10	than	than	ADP
eurjchem-1084	87	11	monocyte	monocyte	NOUN
eurjchem-1084	87	12	chemotactic	chemotactic	ADJ
eurjchem-1084	87	13	protein‐1	protein‐1	NOUN
eurjchem-1084	87	14	(	(	PUNCT
eurjchem-1084	87	15	mcp‐1	mcp‐1	NOUN
eurjchem-1084	87	16	)	)	PUNCT
eurjchem-1084	87	17	for	for	ADP
eurjchem-1084	87	18	mediating	mediate	VERB
eurjchem-1084	87	19	monocyte	monocyte	NOUN
eurjchem-1084	87	20	adhesion	adhesion	NOUN
eurjchem-1084	87	21	.	.	PUNCT
eurjchem-1084	88	1	yeh	yeh	PROPN
eurjchem-1084	88	2	and	and	CCONJ
eurjchem-1084	88	3	berliner	berliner	PROPN
eurjchem-1084	89	1	[	[	X
eurjchem-1084	89	2	14	14	NUM
eurjchem-1084	89	3	]	]	PUNCT
eurjchem-1084	89	4	have	have	AUX
eurjchem-1084	89	5	recently	recently	ADV
eurjchem-1084	89	6	shown	show	VERB
eurjchem-1084	89	7	that	that	SCONJ
eurjchem-1084	89	8	il‐8	il‐8	PROPN
eurjchem-1084	89	9	is	be	AUX
eurjchem-1084	89	10	a	a	DET
eurjchem-1084	89	11	mediator	mediator	NOUN
eurjchem-1084	89	12	of	of	ADP
eurjchem-1084	89	13	oxidized	oxidize	VERB
eurjchem-1084	89	14	phospholipid	phospholipid	NOUN
eurjchem-1084	89	15	activation	activation	NOUN
eurjchem-1084	89	16	of	of	ADP
eurjchem-1084	89	17	monocyte	monocyte	NOUN
eurjchem-1084	89	18	.	.	PUNCT
eurjchem-1084	90	1	4	4	NUM
eurjchem-1084	90	2	.	.	X
eurjchem-1084	90	3	conclusions	conclusion	NOUN
eurjchem-1084	90	4	‐	‐	VERB
eurjchem-1084	90	5	interleukin‐8	interleukin‐8	ADP
eurjchem-1084	90	6	positively	positively	ADV
eurjchem-1084	90	7	correlated	correlate	VERB
eurjchem-1084	90	8	with	with	ADP
eurjchem-1084	90	9	bmi	bmi	NOUN
eurjchem-1084	90	10	in	in	ADP
eurjchem-1084	90	11	patients	patient	NOUN
eurjchem-1084	90	12	and	and	CCONJ
eurjchem-1084	90	13	control	control	NOUN
eurjchem-1084	90	14	groups	group	NOUN
eurjchem-1084	90	15	and	and	CCONJ
eurjchem-1084	90	16	that	that	PRON
eurjchem-1084	90	17	lead	lead	VERB
eurjchem-1084	90	18	us	we	PRON
eurjchem-1084	90	19	to	to	PART
eurjchem-1084	90	20	consider	consider	VERB
eurjchem-1084	90	21	il‐8	il‐8	PRON
eurjchem-1084	90	22	increases	increase	NOUN
eurjchem-1084	90	23	with	with	ADP
eurjchem-1084	90	24	obesity	obesity	NOUN
eurjchem-1084	90	25	.	.	PUNCT
eurjchem-1084	91	1	‐	‐	NOUN
eurjchem-1084	91	2	interleukin‐8	interleukin‐8	VERB
eurjchem-1084	91	3	positively	positively	ADV
eurjchem-1084	91	4	correlated	correlate	VERB
eurjchem-1084	91	5	with	with	ADP
eurjchem-1084	91	6	ldl‐cholesterol	ldl‐cholesterol	NOUN
eurjchem-1084	91	7	and	and	CCONJ
eurjchem-1084	91	8	negatively	negatively	ADV
eurjchem-1084	91	9	correlated	correlate	VERB
eurjchem-1084	91	10	with	with	ADP
eurjchem-1084	91	11	hdl‐c	hdl‐c	NOUN
eurjchem-1084	91	12	thus	thus	ADV
eurjchem-1084	91	13	makes	make	VERB
eurjchem-1084	91	14	us	we	PRON
eurjchem-1084	91	15	consider	consider	VERB
eurjchem-1084	91	16	it	it	PRON
eurjchem-1084	91	17	as	as	ADP
eurjchem-1084	91	18	atherogenic	atherogenic	ADJ
eurjchem-1084	91	19	factor	factor	NOUN
eurjchem-1084	91	20	.	.	PUNCT
eurjchem-1084	92	1	‐	‐	ADP
eurjchem-1084	92	2	the	the	DET
eurjchem-1084	92	3	increase	increase	NOUN
eurjchem-1084	92	4	in	in	ADP
eurjchem-1084	92	5	the	the	DET
eurjchem-1084	92	6	level	level	NOUN
eurjchem-1084	92	7	of	of	ADP
eurjchem-1084	92	8	il‐8	il‐8	NOUN
eurjchem-1084	92	9	in	in	ADP
eurjchem-1084	92	10	patients	patient	NOUN
eurjchem-1084	92	11	who	who	PRON
eurjchem-1084	92	12	have	have	VERB
eurjchem-1084	92	13	diabetes	diabetes	NOUN
eurjchem-1084	92	14	mellitus	mellitus	NOUN
eurjchem-1084	92	15	may	may	AUX
eurjchem-1084	92	16	indicate	indicate	VERB
eurjchem-1084	92	17	increasing	increase	VERB
eurjchem-1084	92	18	the	the	DET
eurjchem-1084	92	19	incidence	incidence	NOUN
eurjchem-1084	92	20	of	of	ADP
eurjchem-1084	92	21	atherosclerosis	atherosclerosis	NOUN
eurjchem-1084	92	22	so	so	SCONJ
eurjchem-1084	92	23	this	this	DET
eurjchem-1084	92	24	relation	relation	NOUN
eurjchem-1084	92	25	can	can	AUX
eurjchem-1084	92	26	indicate	indicate	VERB
eurjchem-1084	92	27	the	the	DET
eurjchem-1084	92	28	tendency	tendency	NOUN
eurjchem-1084	92	29	of	of	ADP
eurjchem-1084	92	30	patients	patient	NOUN
eurjchem-1084	92	31	toward	toward	ADP
eurjchem-1084	92	32	atherosclerosis	atherosclerosis	NOUN
eurjchem-1084	92	33	.	.	PUNCT
eurjchem-1084	93	1	ibrahim	ibrahim	PROPN
eurjchem-1084	93	2	/	/	SYM
eurjchem-1084	93	3	european	european	PROPN
eurjchem-1084	93	4	journal	journal	PROPN
eurjchem-1084	93	5	of	of	ADP
eurjchem-1084	93	6	chemistry	chemistry	NOUN
eurjchem-1084	93	7	5	5	NUM
eurjchem-1084	93	8	(	(	PUNCT
eurjchem-1084	93	9	3	3	NUM
eurjchem-1084	93	10	)	)	PUNCT
eurjchem-1084	93	11	(	(	PUNCT
eurjchem-1084	93	12	2014	2014	NUM
eurjchem-1084	93	13	)	)	PUNCT
eurjchem-1084	94	1	529‐531	529‐531	NUM
eurjchem-1084	94	2	531	531	NUM
eurjchem-1084	94	3	references	reference	NOUN
eurjchem-1084	94	4	[	[	X
eurjchem-1084	94	5	1	1	NUM
eurjchem-1084	94	6	]	]	PUNCT
eurjchem-1084	94	7	.	.	PUNCT
eurjchem-1084	95	1	suseela	suseela	PROPN
eurjchem-1084	95	2	,	,	PUNCT
eurjchem-1084	95	3	s.	s.	PROPN
eurjchem-1084	95	4	;	;	PUNCT
eurjchem-1084	95	5	michael	michael	PROPN
eurjchem-1084	95	6	,	,	PUNCT
eurjchem-1084	95	7	y.	y.	PROPN
eurjchem-1084	95	8	;	;	PUNCT
eurjchem-1084	95	9	eric	eric	PROPN
eurjchem-1084	95	10	,	,	PUNCT
eurjchem-1084	95	11	c.	c.	PROPN
eurjchem-1084	95	12	;	;	PUNCT
eurjchem-1084	95	13	melissa	melissa	PROPN
eurjchem-1084	95	14	,	,	PUNCT
eurjchem-1084	95	15	e.	e.	PROPN
eurjchem-1084	95	16	;	;	PUNCT
eurjchem-1084	95	17	hatley	hatley	PROPN
eurjchem-1084	95	18	,	,	PUNCT
eurjchem-1084	95	19	a.	a.	PROPN
eurjchem-1084	95	20	e.	e.	PROPN
eurjchem-1084	95	21	circ	circ	PROPN
eurjchem-1084	95	22	.	.	PUNCT
eurjchem-1084	96	1	res	re	NOUN
eurjchem-1084	96	2	.	.	PROPN
eurjchem-1084	96	3	2003	2003	NUM
eurjchem-1084	96	4	,	,	PUNCT
eurjchem-1084	96	5	92	92	NUM
eurjchem-1084	96	6	,	,	PUNCT
eurjchem-1084	96	7	371‐377	371‐377	NUM
eurjchem-1084	96	8	.	.	PUNCT
eurjchem-1084	97	1	[	[	X
eurjchem-1084	97	2	2	2	NUM
eurjchem-1084	97	3	]	]	PUNCT
eurjchem-1084	97	4	.	.	PUNCT
eurjchem-1084	98	1	gross	gross	ADJ
eurjchem-1084	98	2	,	,	PUNCT
eurjchem-1084	98	3	m.	m.	NOUN
eurjchem-1084	98	4	d.	d.	PROPN
eurjchem-1084	98	5	;	;	PUNCT
eurjchem-1084	98	6	shapiro	shapiro	PROPN
eurjchem-1084	98	7	,	,	PUNCT
eurjchem-1084	98	8	b.	b.	PROPN
eurjchem-1084	98	9	;	;	PUNCT
eurjchem-1084	98	10	fig	fig	PROPN
eurjchem-1084	98	11	,	,	PUNCT
eurjchem-1084	98	12	l.	l.	PROPN
eurjchem-1084	98	13	m.	m.	PROPN
eurjchem-1084	98	14	;	;	PUNCT
eurjchem-1084	98	15	steventon	steventon	PROPN
eurjchem-1084	98	16	,	,	PUNCT
eurjchem-1084	98	17	r.	r.	PROPN
eurjchem-1084	98	18	;	;	PUNCT
eurjchem-1084	98	19	skinner	skinner	PROPN
eurjchem-1084	98	20	,	,	PUNCT
eurjchem-1084	98	21	r.	r.	PROPN
eurjchem-1084	98	22	w.	w.	PROPN
eurjchem-1084	98	23	s.	s.	PROPN
eurjchem-1084	98	24	;	;	PUNCT
eurjchem-1084	98	25	hay	hay	PROPN
eurjchem-1084	98	26	,	,	PUNCT
eurjchem-1084	98	27	r.	r.	PROPN
eurjchem-1084	98	28	v.	v.	PROPN
eurjchem-1084	98	29	j.	j.	PROPN
eurjchem-1084	98	30	nucl	nucl	PROPN
eurjchem-1084	98	31	.	.	PUNCT
eurjchem-1084	99	1	med	med	PROPN
eurjchem-1084	99	2	.	.	PROPN
eurjchem-1084	99	3	2001	2001	NUM
eurjchem-1084	99	4	,	,	PUNCT
eurjchem-1084	99	5	42(11	42(11	NUM
eurjchem-1084	99	6	)	)	PUNCT
eurjchem-1084	99	7	,	,	PUNCT
eurjchem-1084	99	8	1656‐1659	1656‐1659	NUM
eurjchem-1084	99	9	.	.	PUNCT
eurjchem-1084	100	1	[	[	X
eurjchem-1084	100	2	3	3	NUM
eurjchem-1084	100	3	]	]	PUNCT
eurjchem-1084	100	4	.	.	PUNCT
eurjchem-1084	101	1	american	american	ADJ
eurjchem-1084	101	2	society	society	PROPN
eurjchem-1084	101	3	of	of	ADP
eurjchem-1084	101	4	health‐system	health‐system	NOUN
eurjchem-1084	101	5	pharmacists	pharmacist	NOUN
eurjchem-1084	101	6	(	(	PUNCT
eurjchem-1084	101	7	2009‐02‐01	2009‐02‐01	NUM
eurjchem-1084	101	8	)	)	PUNCT
eurjchem-1084	101	9	.	.	PUNCT
eurjchem-1084	102	1	insulin	insulin	NOUN
eurjchem-1084	102	2	injection	injection	NOUN
eurjchem-1084	102	3	.	.	PUNCT
eurjchem-1084	103	1	pubmed	pubmed	PROPN
eurjchem-1084	103	2	health	health	PROPN
eurjchem-1084	103	3	.	.	PUNCT
eurjchem-1084	104	1	national	national	ADJ
eurjchem-1084	104	2	center	center	NOUN
eurjchem-1084	104	3	for	for	ADP
eurjchem-1084	104	4	biotechnology	biotechnology	NOUN
eurjchem-1084	104	5	information	information	NOUN
eurjchem-1084	104	6	,	,	PUNCT
eurjchem-1084	104	7	u.	u.	PROPN
eurjchem-1084	104	8	s.	s.	PROPN
eurjchem-1084	104	9	national	national	PROPN
eurjchem-1084	104	10	library	library	PROPN
eurjchem-1084	104	11	of	of	ADP
eurjchem-1084	104	12	medicine	medicine	NOUN
eurjchem-1084	104	13	.	.	PUNCT
eurjchem-1084	105	1	retrieved	retrieve	VERB
eurjchem-1084	105	2	2012‐10‐12	2012‐10‐12	NUM
eurjchem-1084	105	3	.	.	PUNCT
eurjchem-1084	106	1	[	[	X
eurjchem-1084	106	2	4	4	NUM
eurjchem-1084	106	3	]	]	PUNCT
eurjchem-1084	106	4	.	.	PUNCT
eurjchem-1084	107	1	rao	rao	PROPN
eurjchem-1084	107	2	,	,	PUNCT
eurjchem-1084	107	3	u.	u.	PROPN
eurjchem-1084	107	4	m.	m.	PROPN
eurjchem-1084	107	5	;	;	PUNCT
eurjchem-1084	107	6	sreenivasulu	sreenivasulu	PROPN
eurjchem-1084	107	7	,	,	PUNCT
eurjchem-1084	107	8	m.	m.	NOUN
eurjchem-1084	107	9	;	;	PUNCT
eurjchem-1084	107	10	chengaiah	chengaiah	PROPN
eurjchem-1084	107	11	,	,	PUNCT
eurjchem-1084	107	12	b.	b.	PROPN
eurjchem-1084	107	13	;	;	PUNCT
eurjchem-1084	107	14	reddy	reddy	PROPN
eurjchem-1084	107	15	,	,	PUNCT
eurjchem-1084	107	16	k.	k.	PROPN
eurjchem-1084	107	17	c.	c.	PROPN
eurjchem-1084	107	18	;	;	PUNCT
eurjchem-1084	107	19	chetty	chetty	PROPN
eurjchem-1084	107	20	,	,	PUNCT
eurjchem-1084	107	21	c.	c.	PROPN
eurjchem-1084	107	22	m.	m.	PROPN
eurjchem-1084	107	23	int	int	PROPN
eurjchem-1084	107	24	.	.	PUNCT
eurjchem-1084	108	1	j.	j.	PROPN
eurjchem-1084	108	2	pharmtech	pharmtech	PROPN
eurjchem-1084	108	3	.	.	PUNCT
eurjchem-1084	109	1	res	re	NOUN
eurjchem-1084	109	2	.	.	PUNCT
eurjchem-1084	110	1	2010	2010	NUM
eurjchem-1084	110	2	,	,	PUNCT
eurjchem-1084	110	3	2(3	2(3	NUM
eurjchem-1084	110	4	)	)	PUNCT
eurjchem-1084	110	5	,	,	PUNCT
eurjchem-1084	110	6	1883‐1892	1883‐1892	NUM
eurjchem-1084	110	7	.	.	PUNCT
eurjchem-1084	111	1	[	[	X
eurjchem-1084	111	2	5	5	NUM
eurjchem-1084	111	3	]	]	PUNCT
eurjchem-1084	111	4	.	.	PUNCT
eurjchem-1084	111	5	mohamed‐ali	mohamed‐ali	PROPN
eurjchem-1084	111	6	,	,	PUNCT
eurjchem-1084	111	7	v.	v.	PROPN
eurjchem-1084	111	8	;	;	PUNCT
eurjchem-1084	111	9	goodrick	goodrick	NOUN
eurjchem-1084	111	10	,	,	PUNCT
eurjchem-1084	111	11	s.	s.	PROPN
eurjchem-1084	111	12	;	;	PUNCT
eurjchem-1084	111	13	rawesh	rawesh	NOUN
eurjchem-1084	111	14	,	,	PUNCT
eurjchem-1084	111	15	a.	a.	PROPN
eurjchem-1084	111	16	;	;	PUNCT
eurjchem-1084	111	17	katz	katz	PROPN
eurjchem-1084	111	18	,	,	PUNCT
eurjchem-1084	111	19	d.	d.	PROPN
eurjchem-1084	111	20	r.	r.	PROPN
eurjchem-1084	111	21	;	;	PUNCT
eurjchem-1084	111	22	miles	mile	NOUN
eurjchem-1084	111	23	,	,	PUNCT
eurjchem-1084	111	24	j.	j.	PROPN
eurjchem-1084	111	25	m.	m.	PROPN
eurjchem-1084	111	26	;	;	PUNCT
eurjchem-1084	111	27	yudkin	yudkin	PROPN
eurjchem-1084	111	28	,	,	PUNCT
eurjchem-1084	111	29	j.	j.	PROPN
eurjchem-1084	111	30	s.	s.	PROPN
eurjchem-1084	111	31	j.	j.	PROPN
eurjchem-1084	111	32	clin	clin	PROPN
eurjchem-1084	111	33	.	.	PUNCT
eurjchem-1084	112	1	endocr	endocr	PROPN
eurjchem-1084	112	2	.	.	PUNCT
eurjchem-1084	113	1	metab	metab	PROPN
eurjchem-1084	113	2	.	.	PUNCT
eurjchem-1084	114	1	1997	1997	NUM
eurjchem-1084	114	2	,	,	PUNCT
eurjchem-1084	114	3	82	82	NUM
eurjchem-1084	114	4	,	,	PUNCT
eurjchem-1084	114	5	4196‐4200	4196‐4200	NUM
eurjchem-1084	114	6	.	.	PUNCT
eurjchem-1084	115	1	[	[	X
eurjchem-1084	115	2	6	6	NUM
eurjchem-1084	115	3	]	]	PUNCT
eurjchem-1084	115	4	.	.	PUNCT
eurjchem-1084	116	1	hotamisligil	hotamisligil	PROPN
eurjchem-1084	116	2	,	,	PUNCT
eurjchem-1084	116	3	g.	g.	PROPN
eurjchem-1084	116	4	s.	s.	PROPN
eurjchem-1084	116	5	;	;	PUNCT
eurjchem-1084	116	6	spiegelman	spiegelman	NOUN
eurjchem-1084	116	7	,	,	PUNCT
eurjchem-1084	116	8	b.	b.	PROPN
eurjchem-1084	116	9	m.	m.	PROPN
eurjchem-1084	116	10	diabetes	diabetes	PROPN
eurjchem-1084	116	11	1994	1994	NUM
eurjchem-1084	116	12	,	,	PUNCT
eurjchem-1084	116	13	43	43	NUM
eurjchem-1084	116	14	,	,	PUNCT
eurjchem-1084	116	15	1271‐1278	1271‐1278	NUM
eurjchem-1084	116	16	.	.	PUNCT
eurjchem-1084	117	1	[	[	X
eurjchem-1084	117	2	7	7	NUM
eurjchem-1084	117	3	]	]	PUNCT
eurjchem-1084	117	4	.	.	PUNCT
eurjchem-1084	117	5	bruun	bruun	PROPN
eurjchem-1084	117	6	,	,	PUNCT
eurjchem-1084	117	7	j.	j.	PROPN
eurjchem-1084	117	8	m.	m.	PROPN
eurjchem-1084	117	9	;	;	PUNCT
eurjchem-1084	117	10	pedersen	pedersen	PROPN
eurjchem-1084	117	11	,	,	PUNCT
eurjchem-1084	117	12	s.	s.	PROPN
eurjchem-1084	117	13	b.	b.	PROPN
eurjchem-1084	117	14	;	;	PUNCT
eurjchem-1084	117	15	richelsen	richelsen	PROPN
eurjchem-1084	117	16	,	,	PUNCT
eurjchem-1084	117	17	b.	b.	PROPN
eurjchem-1084	117	18	j.	j.	PROPN
eurjchem-1084	117	19	clin	clin	PROPN
eurjchem-1084	117	20	.	.	PUNCT
eurjchem-1084	118	1	endocr	endocr	PROPN
eurjchem-1084	118	2	.	.	PUNCT
eurjchem-1084	119	1	metab	metab	PROPN
eurjchem-1084	119	2	.	.	PUNCT
eurjchem-1084	120	1	2001	2001	NUM
eurjchem-1084	120	2	,	,	PUNCT
eurjchem-1084	120	3	86	86	NUM
eurjchem-1084	120	4	,	,	PUNCT
eurjchem-1084	120	5	1267‐1273	1267‐1273	NUM
eurjchem-1084	120	6	.	.	PUNCT
eurjchem-1084	121	1	[	[	X
eurjchem-1084	121	2	8	8	NUM
eurjchem-1084	121	3	]	]	PUNCT
eurjchem-1084	121	4	.	.	PUNCT
eurjchem-1084	122	1	gerhardt	gerhardt	PROPN
eurjchem-1084	122	2	,	,	PUNCT
eurjchem-1084	122	3	c.	c.	PROPN
eurjchem-1084	122	4	c.	c.	PROPN
eurjchem-1084	122	5	;	;	PUNCT
eurjchem-1084	122	6	romero	romero	PROPN
eurjchem-1084	122	7	,	,	PUNCT
eurjchem-1084	122	8	i.	i.	PROPN
eurjchem-1084	122	9	a.	a.	PROPN
eurjchem-1084	122	10	;	;	PUNCT
eurjchem-1084	122	11	cancello	cancello	PROPN
eurjchem-1084	122	12	,	,	PUNCT
eurjchem-1084	122	13	r.	r.	PROPN
eurjchem-1084	122	14	;	;	PUNCT
eurjchem-1084	122	15	camoin	camoin	PROPN
eurjchem-1084	122	16	,	,	PUNCT
eurjchem-1084	122	17	l.	l.	PROPN
eurjchem-1084	122	18	;	;	PUNCT
eurjchem-1084	122	19	strosberg	strosberg	PROPN
eurjchem-1084	122	20	,	,	PUNCT
eurjchem-1084	122	21	a.	a.	PROPN
eurjchem-1084	122	22	d.	d.	PROPN
eurjchem-1084	122	23	mol	mol	PROPN
eurjchem-1084	122	24	.	.	PROPN
eurjchem-1084	123	1	cell	cell	NOUN
eurjchem-1084	123	2	.	.	PUNCT
eurjchem-1084	124	1	endocrinol	endocrinol	NOUN
eurjchem-1084	124	2	.	.	PUNCT
eurjchem-1084	125	1	2001	2001	NUM
eurjchem-1084	125	2	,	,	PUNCT
eurjchem-1084	125	3	175	175	NUM
eurjchem-1084	125	4	,	,	PUNCT
eurjchem-1084	125	5	81‐92	81‐92	NOUN
eurjchem-1084	125	6	.	.	PUNCT
eurjchem-1084	126	1	[	[	X
eurjchem-1084	126	2	9	9	NUM
eurjchem-1084	126	3	]	]	PUNCT
eurjchem-1084	126	4	.	.	PUNCT
eurjchem-1084	126	5	shin	shin	PROPN
eurjchem-1084	126	6	,	,	PUNCT
eurjchem-1084	126	7	w.	w.	PROPN
eurjchem-1084	126	8	s.	s.	PROPN
eurjchem-1084	126	9	;	;	PUNCT
eurjchem-1084	126	10	szuba	szuba	PROPN
eurjchem-1084	126	11	,	,	PUNCT
eurjchem-1084	126	12	a.	a.	NOUN
eurjchem-1084	126	13	;	;	PUNCT
eurjchem-1084	126	14	rockson	rockson	PROPN
eurjchem-1084	126	15	,	,	PUNCT
eurjchem-1084	126	16	s.	s.	PROPN
eurjchem-1084	126	17	g.	g.	PROPN
eurjchem-1084	126	18	atherosclerosis	atherosclerosis	PROPN
eurjchem-1084	126	19	2002	2002	NUM
eurjchem-1084	126	20	,	,	PUNCT
eurjchem-1084	126	21	160	160	NUM
eurjchem-1084	126	22	,	,	PUNCT
eurjchem-1084	126	23	91‐102	91‐102	NUM
eurjchem-1084	126	24	.	.	PUNCT
eurjchem-1084	127	1	[	[	X
eurjchem-1084	127	2	10	10	NUM
eurjchem-1084	127	3	]	]	PUNCT
eurjchem-1084	127	4	.	.	PUNCT
eurjchem-1084	128	1	kopelman	kopelman	PROPN
eurjchem-1084	128	2	,	,	PUNCT
eurjchem-1084	128	3	p.	p.	NOUN
eurjchem-1084	128	4	g.	g.	PROPN
eurjchem-1084	128	5	nature	nature	PROPN
eurjchem-1084	128	6	2000	2000	NUM
eurjchem-1084	128	7	,	,	PUNCT
eurjchem-1084	128	8	404	404	NUM
eurjchem-1084	128	9	,	,	PUNCT
eurjchem-1084	128	10	635‐643	635‐643	PROPN
eurjchem-1084	128	11	.	.	PUNCT
eurjchem-1084	129	1	[	[	X
eurjchem-1084	129	2	11	11	NUM
eurjchem-1084	129	3	]	]	PUNCT
eurjchem-1084	129	4	.	.	PUNCT
eurjchem-1084	129	5	bruun	bruun	PROPN
eurjchem-1084	129	6	,	,	PUNCT
eurjchem-1084	129	7	j.	j.	PROPN
eurjchem-1084	129	8	m.	m.	PROPN
eurjchem-1084	129	9	;	;	PUNCT
eurjchem-1084	129	10	pedersen	pedersen	PROPN
eurjchem-1084	129	11	,	,	PUNCT
eurjchem-1084	129	12	s.	s.	PROPN
eurjchem-1084	129	13	b.	b.	PROPN
eurjchem-1084	129	14	;	;	PUNCT
eurjchem-1084	129	15	kristensen	kristensen	PROPN
eurjchem-1084	129	16	,	,	PUNCT
eurjchem-1084	129	17	k.	k.	PROPN
eurjchem-1084	129	18	;	;	PUNCT
eurjchem-1084	129	19	richelsen	richelsen	PROPN
eurjchem-1084	129	20	,	,	PUNCT
eurjchem-1084	129	21	b.	b.	PROPN
eurjchem-1084	129	22	obes	obes	PROPN
eurjchem-1084	129	23	.	.	PUNCT
eurjchem-1084	130	1	res	re	NOUN
eurjchem-1084	130	2	.	.	PROPN
eurjchem-1084	130	3	2002	2002	NUM
eurjchem-1084	130	4	,	,	PUNCT
eurjchem-1084	130	5	10	10	NUM
eurjchem-1084	130	6	,	,	PUNCT
eurjchem-1084	130	7	499‐506	499‐506	NOUN
eurjchem-1084	130	8	.	.	PUNCT
eurjchem-1084	131	1	[	[	X
eurjchem-1084	131	2	12	12	NUM
eurjchem-1084	131	3	]	]	PUNCT
eurjchem-1084	131	4	.	.	PUNCT
eurjchem-1084	132	1	gerszten	gerszten	PROPN
eurjchem-1084	132	2	,	,	PUNCT
eurjchem-1084	132	3	r.	r.	PROPN
eurjchem-1084	132	4	e.	e.	PROPN
eurjchem-1084	132	5	;	;	PUNCT
eurjchem-1084	132	6	garcia‐zepeda	garcia‐zepeda	PROPN
eurjchem-1084	132	7	,	,	PUNCT
eurjchem-1084	132	8	e.	e.	PROPN
eurjchem-1084	132	9	a.	a.	PROPN
eurjchem-1084	132	10	;	;	PUNCT
eurjchem-1084	132	11	lim	lim	PROPN
eurjchem-1084	132	12	,	,	PUNCT
eurjchem-1084	132	13	y.	y.	PROPN
eurjchem-1084	132	14	c.	c.	PROPN
eurjchem-1084	132	15	;	;	PUNCT
eurjchem-1084	132	16	yoshida	yoshida	PROPN
eurjchem-1084	132	17	,	,	PUNCT
eurjchem-1084	132	18	m.	m.	NOUN
eurjchem-1084	132	19	;	;	PUNCT
eurjchem-1084	132	20	ding	ding	NOUN
eurjchem-1084	132	21	,	,	PUNCT
eurjchem-1084	132	22	h.	h.	PROPN
eurjchem-1084	132	23	a.	a.	PROPN
eurjchem-1084	132	24	;	;	PUNCT
eurjchem-1084	132	25	gimbrone	gimbrone	NOUN
eurjchem-1084	132	26	,	,	PUNCT
eurjchem-1084	132	27	m.	m.	NOUN
eurjchem-1084	132	28	a.	a.	PROPN
eurjchem-1084	132	29	jr	jr	PROPN
eurjchem-1084	132	30	.	.	PROPN
eurjchem-1084	132	31	;	;	PUNCT
eurjchem-1084	132	32	luster	luster	NOUN
eurjchem-1084	132	33	,	,	PUNCT
eurjchem-1084	132	34	a.	a.	PROPN
eurjchem-1084	132	35	d.	d.	PROPN
eurjchem-1084	132	36	;	;	PUNCT
eurjchem-1084	132	37	luscinskas	luscinskas	PROPN
eurjchem-1084	132	38	,	,	PUNCT
eurjchem-1084	132	39	f.	f.	PROPN
eurjchem-1084	132	40	w.	w.	PROPN
eurjchem-1084	132	41	;	;	PUNCT
eurjchem-1084	132	42	rosenzweig	rosenzweig	PROPN
eurjchem-1084	132	43	,	,	PUNCT
eurjchem-1084	132	44	a.	a.	NOUN
eurjchem-1084	132	45	nature	nature	NOUN
eurjchem-1084	132	46	1999	1999	NUM
eurjchem-1084	132	47	,	,	PUNCT
eurjchem-1084	132	48	398	398	NUM
eurjchem-1084	132	49	,	,	PUNCT
eurjchem-1084	132	50	718‐723	718‐723	PROPN
eurjchem-1084	132	51	.	.	PUNCT
eurjchem-1084	133	1	[	[	X
eurjchem-1084	133	2	13	13	NUM
eurjchem-1084	133	3	]	]	PUNCT
eurjchem-1084	133	4	.	.	PUNCT
eurjchem-1084	134	1	huo	huo	NOUN
eurjchem-1084	134	2	,	,	PUNCT
eurjchem-1084	134	3	y.	y.	PROPN
eurjchem-1084	134	4	;	;	PUNCT
eurjchem-1084	134	5	weber	weber	PROPN
eurjchem-1084	134	6	,	,	PUNCT
eurjchem-1084	134	7	c.	c.	PROPN
eurjchem-1084	134	8	;	;	PUNCT
eurjchem-1084	134	9	forlow	forlow	PROPN
eurjchem-1084	134	10	,	,	PUNCT
eurjchem-1084	134	11	s.	s.	PROPN
eurjchem-1084	134	12	b.	b.	PROPN
eurjchem-1084	134	13	;	;	PUNCT
eurjchem-1084	134	14	sperandio	sperandio	NOUN
eurjchem-1084	134	15	,	,	PUNCT
eurjchem-1084	134	16	m.	m.	NOUN
eurjchem-1084	134	17	;	;	PUNCT
eurjchem-1084	134	18	thatte	thatte	NOUN
eurjchem-1084	134	19	,	,	PUNCT
eurjchem-1084	134	20	j.	j.	PROPN
eurjchem-1084	134	21	;	;	PUNCT
eurjchem-1084	134	22	mack	mack	PROPN
eurjchem-1084	134	23	,	,	PUNCT
eurjchem-1084	134	24	m.	m.	NOUN
eurjchem-1084	134	25	;	;	PUNCT
eurjchem-1084	134	26	jung	jung	PROPN
eurjchem-1084	134	27	,	,	PUNCT
eurjchem-1084	134	28	s.	s.	PROPN
eurjchem-1084	134	29	;	;	PUNCT
eurjchem-1084	134	30	littman	littman	PROPN
eurjchem-1084	134	31	,	,	PUNCT
eurjchem-1084	134	32	d.	d.	PROPN
eurjchem-1084	134	33	r.	r.	PROPN
eurjchem-1084	134	34	;	;	PUNCT
eurjchem-1084	134	35	ley	ley	PROPN
eurjchem-1084	134	36	,	,	PUNCT
eurjchem-1084	134	37	k.	k.	PROPN
eurjchem-1084	134	38	j.	j.	PROPN
eurjchem-1084	134	39	clin	clin	PROPN
eurjchem-1084	134	40	.	.	PUNCT
eurjchem-1084	135	1	invest	invest	PROPN
eurjchem-1084	135	2	.	.	PUNCT
eurjchem-1084	136	1	2001	2001	NUM
eurjchem-1084	136	2	,	,	PUNCT
eurjchem-1084	136	3	108	108	NUM
eurjchem-1084	136	4	,	,	PUNCT
eurjchem-1084	136	5	1307‐1314	1307‐1314	NUM
eurjchem-1084	136	6	.	.	PUNCT
eurjchem-1084	137	1	[	[	X
eurjchem-1084	137	2	14	14	NUM
eurjchem-1084	137	3	]	]	PUNCT
eurjchem-1084	137	4	.	.	PUNCT
eurjchem-1084	138	1	yeh	yeh	PROPN
eurjchem-1084	138	2	,	,	PUNCT
eurjchem-1084	138	3	m.	m.	NOUN
eurjchem-1084	138	4	;	;	PUNCT
eurjchem-1084	138	5	leitinger	leitinger	NOUN
eurjchem-1084	138	6	,	,	PUNCT
eurjchem-1084	138	7	n.	n.	PROPN
eurjchem-1084	138	8	;	;	PUNCT
eurjchem-1084	138	9	martin	martin	PROPN
eurjchem-1084	138	10	,	,	PUNCT
eurjchem-1084	138	11	r.	r.	PROPN
eurjchem-1084	138	12	;	;	PUNCT
eurjchem-1084	138	13	onai	onai	NOUN
eurjchem-1084	138	14	,	,	PUNCT
eurjchem-1084	138	15	n.	n.	NOUN
eurjchem-1084	138	16	;	;	PUNCT
eurjchem-1084	138	17	matsushima	matsushima	PROPN
eurjchem-1084	138	18	,	,	PUNCT
eurjchem-1084	138	19	k.	k.	PROPN
eurjchem-1084	138	20	;	;	PUNCT
eurjchem-1084	138	21	vora	vora	PROPN
eurjchem-1084	138	22	,	,	PUNCT
eurjchem-1084	138	23	d.	d.	PROPN
eurjchem-1084	138	24	k.	k.	PROPN
eurjchem-1084	138	25	;	;	PUNCT
eurjchem-1084	138	26	berliner	berliner	PROPN
eurjchem-1084	138	27	,	,	PUNCT
eurjchem-1084	138	28	j.	j.	PROPN
eurjchem-1084	138	29	a.	a.	PROPN
eurjchem-1084	138	30	;	;	PUNCT
eurjchem-1084	138	31	reddy	reddy	PROPN
eurjchem-1084	138	32	,	,	PUNCT
eurjchem-1084	138	33	s.	s.	PROPN
eurjchem-1084	138	34	t.	t.	PROPN
eurjchem-1084	138	35	arterioscler	arterioscler	PROPN
eurjchem-1084	138	36	.	.	PUNCT
eurjchem-1084	139	1	thromb	thromb	PROPN
eurjchem-1084	139	2	.	.	PUNCT
eurjchem-1084	140	1	vasc	vasc	PROPN
eurjchem-1084	140	2	.	.	PUNCT
eurjchem-1084	141	1	biol	biol	PROPN
eurjchem-1084	141	2	.	.	PUNCT
eurjchem-1084	142	1	2001	2001	NUM
eurjchem-1084	142	2	,	,	PUNCT
eurjchem-1084	142	3	21	21	NUM
eurjchem-1084	142	4	,	,	PUNCT
eurjchem-1084	142	5	1585‐1591	1585‐1591	NUM
eurjchem-1084	142	6	.	.	PUNCT
eurjchem-1084	143	1	[	[	X
eurjchem-1084	143	2	15	15	NUM
eurjchem-1084	143	3	]	]	X
eurjchem-1084	143	4	.	.	PUNCT
eurjchem-1084	144	1	sushil	sushil	PROPN
eurjchem-1084	144	2	,	,	PUNCT
eurjchem-1084	144	3	k.	k.	PROPN
eurjchem-1084	144	4	;	;	PUNCT
eurjchem-1084	144	5	justin	justin	PROPN
eurjchem-1084	144	6	,	,	PUNCT
eurjchem-1084	144	7	l.	l.	PROPN
eurjchem-1084	144	8	;	;	PUNCT
eurjchem-1084	144	9	jennifer	jennifer	PROPN
eurjchem-1084	144	10	,	,	PUNCT
eurjchem-1084	144	11	l.	l.	PROPN
eurjchem-1084	144	12	antioxid	antioxid	PROPN
eurjchem-1084	144	13	.	.	PUNCT
eurjchem-1084	145	1	redox	redox	PROPN
eurjchem-1084	145	2	sign	sign	NOUN
eurjchem-1084	145	3	.	.	PUNCT
eurjchem-1084	146	1	2007	2007	NUM
eurjchem-1084	146	2	,	,	PUNCT
eurjchem-1084	146	3	9(10	9(10	NUM
eurjchem-1084	146	4	)	)	PUNCT
eurjchem-1084	146	5	,	,	PUNCT
eurjchem-1084	146	6	1581‐1590	1581‐1590	NUM
eurjchem-1084	146	7	.	.	PUNCT
eurjchem-1084	147	1	[	[	X
eurjchem-1084	147	2	16	16	NUM
eurjchem-1084	147	3	]	]	PUNCT
eurjchem-1084	147	4	.	.	PUNCT
eurjchem-1084	148	1	richelse	richelse	PROPN
eurjchem-1084	148	2	,	,	PUNCT
eurjchem-1084	148	3	j.	j.	PROPN
eurjchem-1084	148	4	m.	m.	PROPN
eurjchem-1084	148	5	;	;	PUNCT
eurjchem-1084	148	6	bruun	bruun	PROPN
eurjchem-1084	148	7	,	,	PUNCT
eurjchem-1084	148	8	c.	c.	PROPN
eurjchem-1084	148	9	v.	v.	PROPN
eurjchem-1084	148	10	;	;	PUNCT
eurjchem-1084	148	11	soren	soren	PROPN
eurjchem-1084	148	12	,	,	PUNCT
eurjchem-1084	148	13	t.	t.	PROPN
eurjchem-1084	148	14	;	;	PUNCT
eurjchem-1084	148	15	arne	arne	VERB
eurjchem-1084	148	16	,	,	PUNCT
eurjchem-1084	148	17	a.	a.	PROPN
eurjchem-1084	148	18	eur	eur	PROPN
eurjchem-1084	148	19	.	.	PUNCT
eurjchem-1084	149	1	j.	j.	PROPN
eurjchem-1084	149	2	endocrinol	endocrinol	PROPN
eurjchem-1084	149	3	.	.	PUNCT
eurjchem-1084	150	1	2003	2003	NUM
eurjchem-1084	150	2	,	,	PUNCT
eurjchem-1084	150	3	148	148	NUM
eurjchem-1084	150	4	,	,	PUNCT
eurjchem-1084	150	5	535‐542	535‐542	NUM
eurjchem-1084	150	6	.	.	PUNCT